EGCG

/ INGREDIENTS / By
  1. A receptor for green tea polyphenol EGCG
  2. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
  3. EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
  4. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase
  5. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications
  6. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives
  7. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice
  8. Effect of EGCG on lipid absorption and plasma lipid levels in rats
  9. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells
  10. Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG
  11. Topical applications of caffeine or (−)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice
  12. Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway
  13. Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice
  14. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5′-AMP-activated protein kinase
  15. Dual mechanisms of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes
  16. Green tea metabolite EGCG protects membranes against oxidative damage in vitro
  17. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR
  18. Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea
  19. Effects of green tea and EGCG on cardiovascular and metabolic health
  20. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer
  21. Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea
  22. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions
  23. Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1β-induced expression of matrix metalloproteinase-1 and-13 in human …
  24. Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease
  25. Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises?
  26. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers …
  27. Anti‐infective properties of epigallocatechin‐3‐gallate (EGCG), a component of green tea
  28. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies
  29. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis
  30. Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice
  31. Thermally-induced protein–polyphenol co-assemblies: beta lactoglobulin-based nanocomplexes as protective nanovehicles for EGCG
  32. Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer’s disease
  33. Inhibition of β-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H2O2 at physiologically relevant EGCG …
  34. Significant longevity-extending effects of EGCG on Caenorhabditis elegans under stress
  35. Antimicrobial activity of the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) against clinical isolates of Stenotrophomonas maltophilia
  36. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer
  37. Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG
  38. Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer
  39. Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1α
  40. Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCG) show efficacy in treating prostate cancer
  41. A Major Constituent of Green Tea, EGCG, Inhibits the Growth of a Human Cervical Cancer Cell Line, CaSki Cells, through Apoptosis, G1 Arrest, and Regulation of …
  42. Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils
  43. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells
  44. Suppression of Wnt signaling by the green tea compound (–)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells requirement of the transcriptional …
  45. Toward the molecular mechanism (s) by which EGCG treatment remodels mature amyloid fibrils
  46. Human hair growth enhancement in vitro by green tea epigallocatechin-3-gallate (EGCG)
  47. EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment
  48. Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG)
  49. The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration …
  50. Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats
  51. Melatonin, xanthurenic acid, resveratrol, EGCG, vitamin C and α‐lipoic acid differentially reduce oxidative DNA damage induced by Fenton reagents: a study of their …
  52. Structural properties of EGCG-induced, nontoxic Alzheimer’s disease Aβ oligomers
  53. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy
  54. Beneficial effects of natural antioxidants EGCG and α-lipoic acid on life span and age-dependent behavioral declines in Caenorhabditis elegans
  55. A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (−)-epigallocatechin gallate [(−)-EGCG]
  56. Can EGCG reduce abdominal fat in obese subjects?
  57. Reaction kinetics of degradation and epimerization of epigallocatechin gallate (EGCG) in aqueous system over a wide temperature range
  58. … and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway …
  59. Effects of quercetin and EGCG on mitochondrial biogenesis and immunity
  60. Protective effects of green tea polyphenols and their major component,(–)-epigallocatechin-3-gallate (EGCG), on 6-hydroxydopamine-induced apoptosis in PC12 cells
  61. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 1: genotoxicity
  62. Anxiolytic properties of green tea polyphenol (−)-epigallocatechin gallate (EGCG)
  63. EGCG blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells
  64. The green tea catechins,(−)-Epigallocatechin-3-gallate (EGCG) and (−)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and …
  65. Anti-inflammatory activity of lipophilic epigallocatechin gallate (EGCG) derivatives in LPS-stimulated murine macrophages
  66. Epigallocatechin gallate (EGCG) attenuates high glucose‐induced insulin signaling blockade in human hepG2 hepatoma cells
  67. Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor
  68. EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells.
  69. The specific anti-cancer activity of green tea (−)-epigallocatechin-3-gallate (EGCG)
  70. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-κB activation in normal human bronchial epithelial cells
  71. EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages
  72. New TNF-α releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or …
  73. Keratinocyte proliferation, differentiation, and apoptosis—differential mechanisms of regulation by curcumin, EGCG and apigenin
  74. Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin
  75. Epigallocatechin-3-O-gallate (EGCG) protects the insulin sensitivity in rat L6 muscle cells exposed to dexamethasone condition
  76. Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation
  77. Enantioselective synthesis of epigallocatechin-3-gallate (EGCG), the active polyphenol component from green tea
  78. (−)-Epigallocatechin-3-gallate (EGCG) maintains κ-casein in its pre-fibrillar state without redirecting its aggregation pathway
  79. EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells
  80. Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer’s amyloid-induced mitochondrial dysfunction
  81. Lipophilized epigallocatechin gallate (EGCG) derivatives as novel antioxidants
  82. EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells
  83. EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and VEGF expression
  84. Antiinflammatory action of EGCG, the main component of green tea, through STAT‐1 inhibition
  85. Thermally-induced β-lactoglobulin–EGCG nanovehicles: loading, stability, sensory and digestive-release study
  86. Epigallocatechin Gallate (EGCG) Stimulates Autophagy in Vascular Endothelial Cells a potential role for reducing lipid accumulation
  87. Inhibition of PI3K/AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor
  88. Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases
  89. Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft …
  90. Induction of regulatory T cells by green tea polyphenol EGCG
  91. Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and γ-tocotrienol in estrogen receptor-positive MCF-7 breast …
  92. … activity, APP regulation and amyloid-β peptide reduction by novel multi-functional brain permeable iron-chelating-antioxidants, M-30 and green tea polyphenol, EGCG
  93. Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin
  94. Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75
  95. Molecular Mechanism of the Inhibition of EGCG on the Alzheimer Aβ1–42 Dimer
  96. Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts
  97. Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic β cells
  98. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 3: teratogenicity and reproductive toxicity studies in rats
  99. Comparative effects of polyphenols from green tea (EGCG) and soybean (genistein) on VEGF and IL-8 release from normal human keratinocytes stimulated with the …
  100. A comparison of 5-fluorouracil and natural chemotherapeutic agents, EGCG and thymoquinone, delivered by sustained drug delivery on colon cancer cells.
  101. AFM study of the differential inhibitory effects of the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) against Gram-positive and Gram-negative bacteria
  102. The green tea polyphenol EGCG potentiates the Antiproliferative activity of c-met and epidermal growth factor receptor inhibitors in non–small cell lung cancer cells
  103. Concise synthesis of dideoxy-epigallocatechin gallate (DO-EGCG) and evaluation of its anti-influenza virus activity
  104. Involvement of ERK and protein tyrosine phosphatase signaling pathways in EGCG-induced cyclooxygenase-2 expression in Raw 264.7 cells
  105. Dual function of (−)-epigallocatechin gallate (EGCG) in healthy human lymphocytes
  106. Plasma-kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers
  107. Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG
  108. Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells
  109. The kinetics and mechanisms of the complex formation and antioxidant behaviour of the polyphenols EGCG and ECG with iron (III)
  110. Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7
  111. Physiological Concentrations of (−)-Epigallocatechin-3-O-Gallate (EGCG) Prevent Chromosomal Damage Induced by Reactive Oxygen Species in WIL2-NS Cells
  112. EGCG protects endothelial cells against PCB 126-induced inflammation through inhibition of AhR and induction of Nrf2-regulated genes
  113. Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCG
  114. Apoptosis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression
  115. Molecular basis for cancer chemoprevention by green tea polyphenol EGCG
  116. Inhibition by epigallocatechin gallate (EGCG) of conjugative R plasmid transfer in Escherichia coli
  117. The main catechin of green tea,(−)-epigallocatechin-3-gallate (EGCG), reduces bleomycin-induced DNA damage in human leucocytes
  118. EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia
  119. Acute neurocognitive effects of epigallocatechin gallate (EGCG)
  120. Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG
  121. Effect of brewing temperature and duration on green tea catechin solubilization: Basis for production of EGC and EGCG-enriched fractions
  122. Inhibition of lipoxygenase by (-)-epigallocatechin gallate: X-ray analysis at 2.1 Å reveals degradation of EGCG and shows soybean LOX-3 complex with EGC instead
  123. Potential benefits of green tea polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid arthritis
  124. EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity
  125. Epigallocatechin gallate (EGCG) mimics insulin action on the transcription factor FOXO1a and elicits cellular responses in the presence and absence of insulin
  126. Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives
  127. Green tea epigallocatechin‐3‐gallate (EGCG) promotes neural progenitor cell proliferation and sonic hedgehog pathway activation during adult hippocampal …
  128. The polyphenol EGCG inhibits amyloid formation less efficiently at phospholipid interfaces than in bulk solution
  129. Fish oil enhances anti-amyloidogenic properties of green tea EGCG in Tg2576 mice
  130. Investigation of the mechanism of enhanced effect of EGCG on huperzine Aʼs inhibition of acetylcholinesterase activity in rats by a multispectroscopic method
  131. Repletion of antioxidant status by EGCG and retardation of oxidative damage induced macromolecular anomalies in aged rats
  132. Green tea polyphenol epigallocatechin-3-gallate (EGCG) induced intermolecular cross-linking of membrane proteins
  133. Antihypertensive Effect of Benifuuki Tea Containing O-Methylated EGCG
  134. (−)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells
  135. Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFκB and AP-1 in the human breast cancer cell line MDA-MB …
  136. The phytochemical, EGCG, extends lifespan by reducing liver and kidney function damage and improving age‐associated inflammation and oxidative stress in healthy …
  137. EGCG induces apoptosis in human laryngeal epidermoid carcinoma Hep2 cells via mitochondria with the release of apoptosis-inducing factor and endonuclease G
  138. Production of green tea EGC-and EGCG-enriched fractions by a two-step extraction procedure
  139. A method for fast determination of epigallocatechin gallate (EGCG), epicatechin (EC), catechin (C) and caffeine (CAF) in green tea using HPLC
  140. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCG) on clinical isolates of pathogenic yeasts
  141. Lipophilised epigallocatechin gallate (EGCG) derivatives and their antioxidant potential in food and biological systems
  142. The 67 kDa laminin receptor as a primary determinant of anti-allergic effects of O-methylated EGCG
  143. Inhibition of NADPH oxidase subunits translocation by tea catechin EGCG in mast cell
  144. EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-γ: Role of JAK/STAT1 signaling and implications for HIV-associated …
  145. EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP
  146. Neuroprotective effects of (−)‐epigallocatechin‐3‐gallate (EGCG) on paraquat‐induced apoptosis in PC12 cells
  147. Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats
  148. TGF-β1-induced epithelial–mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells
  149. Synthesis of a 3, 4, 5-trimethoxybenzoyl ester analogue of epigallocatechin-3-gallate (EGCG): a potential route to the natural product green tea catechin, EGCG
  150. EGCG inhibits cardiomyocyte apoptosis in pressure overload‐induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats1
  151. Epigallocatechin-3-gallate (EGCG) enhances the therapeutic activity of a dental adhesive
  152. Green tea catechins (EGCG and EGC) have modulating effects on the activity of doxorubicin in drug-resistant cell lines.
  153. Synthesis, structure analyses, and characterization of novel epigallocatechin gallate (EGCG) glycosides using the glucansucrase from Leuconostoc mesenteroides B …
  154. Epigallocatechin gallate (EGCG) suppresses β-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and GSK3β activation
  155. Epigallocatechin gallate (EGCG) potentiates the cytotoxicity of rotenone in neuroblastoma SH-SY5Y cells
  156. … activity of epigallocatechin gallate (EGCG) in paraquat-induced microsomal lipid peroxidation—a mechanism of protective effects of EGCG against paraquat toxicity
  157. Resveratrol and EGCG bind directly and distinctively to miR-33a and miR-122 and modulate divergently their levels in hepatic cells
  158. EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin
  159. EGCG attenuates AMPA-induced intracellular calcium increase in hippocampal neurons
  160. Epigallocatechin-3-Gallate (EGCG) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cells
  161. Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines
  162. EGCG and Polyphenon E attenuate inflammation-related mouse colon carcinogenesis induced by AOM plus DDS
  163. The effects of EGCG on fat oxidation and endurance performance in male cyclists
  164. Epigallocatechin-3-gallate (EGCG) affects the antioxidant and immune defense of the rainbow trout, Oncorhynchus mykiss
  165. Site specific interaction of the polyphenol EGCG with the SEVI amyloid precursor peptide PAP (248–286)
  166. Protective effect of quercetin, EGCG, catechin and betaine against oxidative stress induced by ethanol in vitro
  167. Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK‐mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCG
  168. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases
  169. p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG
  170. A pro-drug of the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamine
  171. Epigallocatechin-3-O-gallate (EGCG) attenuates FFAs-induced peripheral insulin resistance through AMPK pathway and insulin signaling pathway in vivo
  172. Evaluation of renal protective effects of the green-tea (EGCG) and red grape resveratrol: role of oxidative stress and inflammatory cytokines
  173. EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase
  174. The tea polyphenols EGCG and EGC repress mRNA expression of human telomerase reverse transcriptase (hTERT) in carcinoma cells
  175. Green tea EGCG suppresses T cell proliferation through impairment of IL-2/IL-2 receptor signaling
  176. Protective effects of EGCG on salivary gland cells treated with γ-radiation or cis-platinum (II) diammine dichloride
  177. Going green: the role of the green tea component EGCG in chemoprevention
  178. EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling
  179. Green tea polyphenol EGCG induces lipid-raft clustering and apoptotic cell death by activating protein kinase Cδ and acid sphingomyelinase through a 67 kDa …
  180. Effects of flavonoid-containing beverages and EGCG on endothelial function
  181. EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression
  182. Highly antibiotic-resistant Acinetobacter baumannii clinical isolates are killed by the green tea polyphenol (–)-epigallocatechin-3-gallate (EGCG)
  183. Anti-proliferative and differentiation-inducing activities of the green tea catechin epigallocatechin-3-gallate (EGCG) on the human eosinophilic leukemia EoL-1 cell line
  184. Impact of quercetin and EGCG on key elements of the Wnt pathway in human colon carcinoma cells
  185. Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren’s syndrome, an autoimmune disease
  186. Aggregation of the salivary proline-rich protein IB5 in the presence of the tannin EGCG
  187. Structure–activity study of epi-gallocatechin gallate (EGCG) analogs as proteasome inhibitors
  188. Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells
  189. Differential growth suppression of human melanoma cells by tea (Camellia sinensis) epicatechins (ECG, EGC and EGCG)
  190. EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer
  191. Evaluation of proteasome-inhibitory and apoptosis-inducing potencies of novel (-)-EGCG analogs and their prodrugs
  192. Protective effects of EGCG or GCg, a green tea catechin epimer, against postischemic myocardial dysfunction in guinea-pig hearts
  193. The EGCG-induced redox-sensitive activation of endothelial nitric oxide synthase and relaxation are critically dependent on hydroxyl moieties
  194. Epigallocatechin gallate (EGCG) inhibits the sulfation of 1-naphthol in a human colon carcinoma cell line, Caco-2
  195. Novel chemotherapeutic and renal protective effects for the green tea (EGCG): role of oxidative stress and inflammatory-cytokine signaling
  196. Anti-melanoma effects of vorinostat in combination with polyphenolic antioxidant (−)-epigallocatechin-3-gallate (EGCG)
  197. Inhibition of catechol-Ο-methyltransferase activity in human breast cancer cells enhances the biological effect of the green tea polyphenol (-)-EGCG
  198. (−) Epigallocatechin-gallate (EGCG) prevents mitochondrial damage in isoproterenol-induced cardiac toxicity in albino Wistar rats: a transmission electron microscopic …
  199. Anti-proliferative effects of green tea polyphenol EGCG on Ha-Ras-induced transformation of intestinal epithelial cells
  200. Protective effect of (−)-epigallocatechin-gallate (EGCG) on lipid peroxide metabolism in isoproterenol induced myocardial infarction in male Wistar rats: A …
  201. EGCG protects against UVB-induced apoptosis via oxidative stress and the JNK1/c-Jun pathway in ARPE19 cells
  202. Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells
  203. Induction of apoptosis by EGCG in selected tumour cell lines in vitro.
  204. Antibacterial and physical properties of EGCG-containing glass ionomer cements
  205. Crystal engineering of green tea epigallocatechin-3-gallate (EGCG) cocrystals and pharmacokinetic modulation in rats
  206. Encapsulation of epigallocatechin-3-gallate (EGCG) using oil-in-water (O/W) submicrometer emulsions stabilized by ι-carrageenan and β-lactoglobulin
  207. Production of monodisperse epigallocatechin gallate (EGCG) microparticles by spray drying for high antioxidant activity retention
  208. Preparation and antioxidant activity of green tea extract enriched in epigallocatechin (EGC) and epigallocatechin gallate (EGCG)
  209. SHP-2 tyrosine phosphatase inhibits p73-dependent apoptosis and expression of a subset of p53 target genes induced by EGCG
  210. NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG
  211. EGCG attenuates high glucose-induced endothelial cell inflammation by suppression of PKC and NF-κB signaling in human umbilical vein endothelial cells
  212. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice
  213. Assessment of DNA damage and lipid peroxidation in diabetic mice: effects of propolis and epigallocatechin gallate (EGCG)
  214. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell …
  215. Green tea polyphenol EGCG sensing motif on the 67-kDa laminin receptor
  216. EGCG protects HT-22 cells against glutamate-induced oxidative stress
  217. Hydrogen peroxide mediates EGCG-induced antioxidant protection in human keratinocytes
  218. Degradation and metabolism of catechin, epigallocatechin-3-gallate (EGCG), and related compounds by the intestinal microbiota in the pig cecum model
  219. (-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma
  220. Effect and mechanism of epigallocatechin-3-gallate (EGCG). against the hydrogen peroxide-induced oxidative damage in human dermal fibroblasts.
  221. The antioxidant epigallocatechin gallate (EGCG) moderates the deleterious effects of maternal hyperthermia on follicle-enclosed oocytes in mice
  222. Green tea constituents (−)-epigallocatechin-3-gallate (EGCG) and gallic acid induce topoisomerase I–and topoisomerase II–DNA complexes in cells mediated by …
  223. Combination of low concentration of (−)-epigallocatechin gallate (EGCG) and curcumin strongly suppresses the growth of non-small cell lung cancer in vitro …
  224. EGCG disaggregates amyloid-like fibrils formed by Plasmodium falciparum merozoite surface protein 2
  225. Complexation of epigallocatechin gallate (a green tea extract, EGCG) with Mn2+: nuclear spin relaxation by the paramagnetic ion
  226. Effects of epigallocatechin-3-gallate (EGCG) on in vitro maturation and fertilization of porcine oocytes
  227. Chemoprevention of head and neck cancer by green tea extract: EGCG—the role of EGFR signaling and “lipid raft”
  228. Mathematical modeling of the stability of green tea catechin epigallocatechin gallate (EGCG) during bread baking
  229. 670 nm laser light and EGCG complementarily reduce amyloid-β aggregates in human neuroblastoma cells: basis for treatment of Alzheimer’s disease?
  230. Relationship between the Biological Activities of Methylated Derivatives of (−)-Epigallocatechin-3-O-gallate (EGCG) and Their Cell Surface Binding Activities
  231. Epigalocatechin-3-gallate (EGCG) downregulates PEA15 and thereby augments TRAIL-mediated apoptosis in malignant glioma
  232. EGCG inhibits the invasion of highly invasive CL1-5 lung cancer cells through suppressing MMP-2 expression via JNK signaling and induces G2/M arrest
  233. Green tea catechin EGCG inhibits ileal apical sodium bile acid transporter ASBT
  234. Celastrol and an EGCG pro-drug exhibit potent chemosensitizing activity in human leukemia cells
  235. Epigallocatechin-gallate (EGCG) regulates autophagy in human retinal pigment epithelial cells: a potential role for reducing UVB light-induced retinal damage
  236. Tea Catechin EGCG Suppresses the mgl Gene Associated with Halitosis
  237. Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process
  238. Catechin stability of EGC-and EGCG-enriched tea drinks produced by a two-step extraction procedure
  239. Proteasome inhibition in human breast cancer cells with high catechol-O-methyltransferase activity by green tea polyphenol EGCG analogs
  240. EGCG induces human mesothelioma cell death by inducing reactive oxygen species and autophagy
  241. Inhibitory effect of epigallocatechin gallate (EGCG), resveratrol, and curcumin on proliferation of human retinal pigment epithelial cells in vitro
  242. Fermentation in vitro of EGCG, GCG and EGCG3″ Me isolated from Oolong tea by human intestinal microbiota
  243. Green tea flavonoid epigallocatechin-3-gallate (EGCG) inhibits cardiac hERG potassium channels
  244. (−)-Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, reduces dichlorodiphenyl-trichloroethane (DDT)-induced cell death in dopaminergic SHSY-5Y cells
  245. Role of neuronal nitric oxide synthase in the antiallodynic effects of intrathecal EGCG in a neuropathic pain rat model
  246. Extraction behavior of caffeine and EGCG from green and black tea
  247. Neuroprotective effects of Epigallocatechin-3-gallate (EGCG) in optic nerve crush model in rats
  248. Inhibition of Leishmania (Leishmania) amazonensis and rat arginases by green tea EGCG,(+)-catechin and (−)-epicatechin: a comparative structural analysis …
  249. Physiological responses of ES-2 ovarian cell line following administration of epigallocatechin-3-gallate (EGCG), thymoquinone (TQ), and selenium (SE).
  250. Antiviral effect of epigallocatechin gallate (EGCG) on influenza A virus
  251. Sex-and strain-dependent effects of epigallocatechin gallate (EGCG) and epicatechin gallate (ECG) in the mouse
  252. Effect of process unit operations and long-term storage on catechin contents in EGCG-enriched tea drink
  253. Elevated polyamines lead to selective induction of apoptosis and inhibition of tumorigenesis by (−)-epigallocatechin-3-gallate (EGCG) in ODC/Ras transgenic mice
  254. Radio-modulatory effects of green tea catechin EGCG on pBR322 plasmid DNA and murine splenocytes against gamma-radiation induced damage
  255. Multiple actions of EGCG, the main component of green tea
  256. The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma
  257. Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCG
  258. Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro
  259. Therapeutic efficacy of topical epigallocatechin gallate (EGCG) in murine dry eye
  260. EGCG inhibits CTGF expression via blocking NF-κB activation in cardiac fibroblast
  261. (−)-Epigallocatechin-3-gallate (EGCG) post-transcriptionally and post-translationally suppresses the cell proliferative protein TROP2 in human colorectal cancer cells
  262. Effect of dietary Polyphenon E and EGCG on lung tumorigenesis in A/J Mice
  263. (−)-Epigallocatechin-3-gallate (EGCG) attenuates peripheral nerve degeneration in rat sciatic nerve crush injury
  264. Protective effects of EGCG on UVB-induced damage in living skin equivalents
  265. Targeting of histamine producing cells by EGCG: a green dart against inflammation?
  266. EGCG Stabilizes p27kip1 in E2-Stimulated MCF-7 Cells through Down-Regulation of the Skp2 Protein
  267. Effects of epigallocatechin-3-gallate (EGCG) on A549 lung cancer tumor growth and angiogenesis
  268. Regulation of vascular endothelial growth factor in endometrial tumour cells by resveratrol and EGCG
  269. Effects of interactions of EGCG and Cd2+ on the growth of PC-3 cells and their mechanisms
  270. EGCG-targeted p57/KIP2 reduces tumorigenicity of oral carcinoma cells: role of c-Jun N-terminal kinase
  271. Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells
  272. Free Zn2+ enhances inhibitory effects of EGCG on the growth of PC‐3 cells
  273. Sodium orthovanadate potentiates EGCG-induced apoptosis that is dependent on the ERK pathway
  274. Preventive effect of (−) epigallocatechin-gallate (EGCG) on lysosomal enzymes in heart and subcellular fractions in isoproterenol-induced myocardial infarcted Wistar …
  275. Role of caveolin-1 in EGCG-mediated protection against linoleic-acid-induced endothelial cell activation
  276. Effects of co-administration of tea epigallocatechin-3-gallate (EGCG) and caffeine on absorption and metabolism of EGCG in humans
  277. Protective effects of epigallocatechin gallate (EGCG) derivatives on azoxymethane-induced colonic carcinogenesis in mice
  278. Concise synthesis of catechin probes enabling analysis and imaging of EGCG
  279. Positive inotropic effects of epigallocatechin‐3‐gallate (EGCG) involve activation of Na+/H+ and Na+/Ca2+ exchangers
  280. Green Tea Polyphenol Epigallocatechin-3 Gallate (EGCG) Affects Gene Expression of Breast Cancer Cells Transformed by the Carcinogen 7,12-Dimethylbenz[a] …
  281. Adsorption of (−)-epigallocatechin-3-gallate (EGCG) onto oat β-glucan
  282. Cloning of a Novel O-Methyltransferase from Camellia sinensis and Synthesis of O-Methylated EGCG and Evaluation of their Bioactivity
  283. Inhibition of proliferation and induction of apoptosis by EGCG in human osteogenic sarcoma (HOS) cells
  284. Development of (−)-epigallocatechin-3-gallate (EGCG)-loaded enteric microparticles with intestinal mucoadhesive property
  285. Early transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumour cells
  286. Optimization of informative spectral variables for the quantification of EGCG in green tea using Fourier transform near-infrared (FT-NIR) spectroscopy and multivariate …
  287. Trypanosoma cruzi: in vitro and in vivo antiproliferative effects of epigallocatechin gallate (EGCG)
  288. Therapeutic potential of EGCG on acute renal damage in a rat model of obstructive nephropathy
  289. Epigallocatechin gallate (EGCG)(TEAVIGO™) does not impair nonhaem-iron absorption in man
  290. EGCG and quercetin protected INS-1 cells in oxidative stress via different mechanisms
  291. EGCG downregulates IL-1RI expression and suppresses IL-1-induced tumorigenic factors in human pancreatic adenocarcinoma cells
  292. Mechanism of the inhibition of the STAT3 signaling pathway by EGCG
  293. Characterization, Antimicrobial Activity, and Mechanism of a High-Performance (−)-Epigallocatechin-3-gallate (EGCG)−CuII/Polyvinyl Alcohol (PVA) Nanofibrous …
  294. Expression of NSAID-activated gene-1 by EGCG in head and neck cancer: involvement of ATM-dependent p53 expression
  295. EGCG blocks TGFβ1-induced CCN2 by suppressing JNK and p38 in buccal fibroblasts
  296. EGCG inhibits proliferation of cardiac fibroblasts in rats with cardiac hypertrophy
  297. The modulation of endothelial cell gene expression by green tea polyphenol‐EGCG
  298. Green tea and its major polyphenol EGCG increase the activity of oral peroxidases
  299. Green Tea-EGCG reduces GFAP associated neuronal loss in HIV-1 Tat transgenic mice
  300. Research on EGCG improving the degenerative changes of the brain in AD model mice induced with chemical drugs
  301. EGCG reducing the susceptibility to cholesterol gallstone formation through the regulation of inflammation
  302. Staphylococcal strains adapted to epigallocathechin gallate (EGCG) show reduced susceptibility to vancomycin, oxacillin and ampicillin, increased heat tolerance …
  303. Synthesis and structure–activity relationships of EGCG analogues, a recently identified Hsp90 inhibitor
  304. (−)-Epigallocatechin-3-O-gallate (EGCG) reverses caffeine-induced anxiogenic-like effects
  305. Novel immunoregulatory properties of EGCG on reducing inflammation in EAE
  306. Ex vivo evaluation of antifibrotic compounds in skin scarring: EGCG and silencing of PAI-1 independently inhibit growth and induce keloid shrinkage
  307. Dihydrotestosterone sensitises LNCaP cells to death induced by epigallocatechin‐3‐gallate (EGCG) or an IGF‐i receptor inhibitor
  308. EGCG, a major component of green tea, inhibits VEGF production by swine granulosa cells
  309. Difference of EGCG adhesion on cell surface between Staphylococcus aureus and Escherichia coli visualized by electron microscopy after novel indirect staining with …
  310. Effect of EGCG, a major component of green tea, on the expression of Ets-1, c-Fos, and c-Jun during angiogenesis in vitro
  311. Mechanism of free Zn (2+) enhancing inhibitory effects of EGCG on the growth of PC-3 cells: interactions with mitochondria
  312. The green tea component EGCG inhibits RNA polymerase III transcription
  313. Investigating the stability of EGCG in aqueous media
  314. (-)-Epigallocatechin gallate (EGCG) prevents isoprenaline-induced cardiac marker enzymes and membrane-bound ATPases.
  315. Comparison of (−)-epigallocatechin-3-O-gallate (EGCG) and O-methyl EGCG bioavailability in rats
  316. Protonation of epigallocatechin-3-gallate (EGCG) results in massive aggregation and reduced oral bioavailability of EGCG-dispersed selenium nanoparticles
  317. Chemoprevention of tobacco smoke-induced lung tumors by inhalation of an epigallocatechin gallate (EGCG) aerosol: a pilot study
  318. EGCG‐rich green tea extract stimulates s RAGE secretion to inhibit S 100 A 12‐RAGE axis through ADAM 10‐mediated ectodomain shedding of extracellular RAGE in …
  319. Phenolic promiscuity in the cell nucleus–epigallocatechingallate (EGCG) and theaflavin-3, 3′-digallate from green and black tea bind to model cell nuclear structures …
  320. NF-κB and AP-1 as molecular targets for chemoprevention with EGCG, a review
  321. EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway
  322. EGCG enhances TRAIL-mediated apoptosis in human melanoma A375 cell line
  323. Modulators of amyloid protein aggregation and toxicity: EGCG and CLR01
  324. A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer
  325. Changes in skeletal muscle proteolytic gene expression after prophylactic supplementation of EGCG and NAC and eccentric damage
  326. Synergistic effect of L-Carnosine and EGCG in the prevention of physiological brain aging
  327. The preventive effect of oral EGCG in a fetal alcohol spectrum disorder mouse model
  328. Effects of EGCG on voltage-gated sodium channels in primary cultures of rat hippocampal CA1 neurons
  329. Epigallocatechin gallate (EGCG) binds to low-density lipoproteins (LDL) and protects them from oxidation and glycation under high-glucose conditions mimicking …
  330. A cellular lipidomic study on the Aβ-induced neurotoxicity and neuroprotective effects of EGCG by using UPLC/MS-based glycerolipids profiling and multivariate …
  331. Interference of EGCG on the Zn (II)-induced conformational transition of silk fibroin as a model protein related to neurodegenerative diseases
  332. Synergistic cell death by EGCG and ibuprofen in DU-145 prostate cancer cell line
  333. Effects of varied EGCG and (+)-catechin concentrations on proinflammatory cytokines mrna expression in cona-stimulated primary white blood cell cultures
  334. (—)‐Epigallocatechin gallate (EGCG) prevents isoprenaline‐induced cardiac toxicity by stabilizing cardiac marker enzymes and membrane‐bound ATPases
  335. Tea catechin (EGCG) and its metabolites as bioantioxidants
  336. A study of stability of (-)-Epigallocatechin gallate (EGCG) from green tea in a frozen product
  337. EGCG inhibit chemical reactivity of iron through forming an Ngal–EGCG–iron complex
  338. Modulation of Ca2+ signals by epigallocatechin-3-gallate (EGCG) in cultured rat hippocampal neurons
  339. Effect of green tea powder (Camellia sinensis L. cv. Benifuuki) particle size on O-methylated EGCG absorption in rats; The Kakegawa Study
  340. EGCG debilitates the persistence of EBV latency by reducing the DNA binding potency of nuclear antigen 1
  341. Electroanalysis of the interaction between (−)-epigallocatechin-3-gallate (EGCG) and amyloid-β in the presence of copper
  342. (-)-Epigallocatechin-3-Gallate (EGCG) Increases the Viability of Serum-Starved A549 Cells Through Its Effect on Akt
  343. Modulation of neuronal activity by EGCG
  344. Combined administration of EGCG and IL-1 receptor antagonist efficiently downregulates IL-1-induced tumorigenic factors in U-2 OS human osteosarcoma …
  345. (−)-Epigallocatechin-3-gallate (EGCG) attenuates functional deficits and morphological alterations by diminishing apoptotic gene overexpression in skeletal muscles …
  346. AFM Probing the Mechanism of Synergistic Effects of the Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate (EGCG) with Cefotaxime against Extended …
  347. EGCG suppresses Fused Toes Homolog protein through p53 in cervical cancer cells
  348. Preparative separation of EGCG from Korean green tea by high performance liquid chromatography
  349. Prediction of supercritical extraction recovery of EGCG using hybrid of Adaptive Neuro-Fuzzy Inference System and mathematical model
  350. Evaluation of the antimicrobial efficacy of green tea extract (EGCG) against streptococcus pyogenes in vitro-biomed 2011.
  351. (−)-Epigallocatechin-gallate (EGCG) stabilize the mitochondrial enzymes and inhibits the apoptosis in cigarette smoke-induced myocardial dysfunction in rats
  352. Oral administration of green tea epigallocatechin-3-gallate (EGCG) reduces amyloid beta deposition in transgenic mouse model of Alzheimer’s disease
  353. SU5416 and EGCG work synergistically and inhibit angiogenic and survival factors and induce cell cycle arrest to promote apoptosis in human malignant …
  354. Pro‑apoptotic and migration‑suppressing potential of EGCG, and the involvement of AMPK in the p53‑mediated modulation of VEGF and MMP‑9 expression
  355. Epigallocatechin gallate (EGCG), influences a murine WEHI-3 leukemia model in vivo through enhancing phagocytosis of macrophages and populations of T-and B …
  356. Underlying mechanism for suppression of vascular smooth muscle cells by green tea polyphenol EGCG released from biodegradable polymers for stent application
  357. Chromosome analysis of mouse zygotes after injecting oocytes with spermatozoa treated in vitro with green tea catechin,(−)-epigallocatechin gallate (EGCG)
  358. Identification of an EGCG oxidation derivative with proteasome modulatory activity
  359. The latest development on EGCG anticancer mechanism
  360. Metabolite modulation of HeLa cell response to ENOX2 inhibitors EGCG and phenoxodiol
  361. Protective activity of different concentration of tea polyphenols and its major compound EGCG against whole body irradiation-induced injury in mice
  362. Semi-synthesis and proteasome inhibition of D-ring deoxy analogs of (–)-epigallocatechin gallate (EGCG), the active ingredient of green tea extract
  363. DHA sensitizes FaO cells to tert-BHP-induced oxidative effects. Protective role of EGCG
  364. A proprietary topical preparation containing EGCG-stearate and glycerin with inhibitory effects on herpes simplex virus: Case study
  365. Evaluation of the bitter-masking potential of food proteins for EGCG by a cell-based human bitter taste receptor assay and binding studies
  366. Attenuated mitochondrial NADP+-dependent isocitrate dehydrogenase activity enhances EGCG-induced apoptosis
  367. Oxygen partial pressure modulates 67-kDa laminin receptor expression, leading to altered activity of the green tea polyphenol, EGCG
  368. Separation and Preparation of Epigallocatechin Gallate (EGCG)[J]
  369. The dual action of epigallocatechin gallate (EGCG), the main constituent of green tea, against the deleterious effects of visible light and singlet oxygen-generating …
  370. EGCG targeting efficacy of NF-κB downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelocytic leukemia cells
  371. Structural perspective on the direct inhibition mechanism of EGCG on mammalian histidine decarboxylase and DOPA decarboxylase
  372. Epigallocatechin-3-gallate (EGCG): A structural target for the development of potential therapeutic drugs against anti-proliferative diseases
  373. Anti-allergic action of 0-methylated EGCG in green tea cultivar benifuuki
  374. EGCG induced apoptosis and expression change of bcl-2 protein in gastric and hepatic carcinoma cells [J]
  375. Epigallocatechin gallate (EGCG) inhibits type II phosphatidylinositol 4-kinases: a key component in pathways of phosphoinositide turnover
  376. Chemopreventive effect of epigallocatechin‐3‐gallate (EGCG) and folic acid on the N‐methyl‐N′‐nitro‐N‐nitrosoguanidine (MNNG)‐induced gastrointestinal cancer …
  377. The mechanisms and effect of epigallocatechin gallate (EGCG) on the germination and proliferation of bacterial spores
  378. A Fast Assembly of (−)‐Epigallocatechin‐3‐gallate [(−)‐EGCG] via Intra‐and Inter‐molecular Mitsunobu Reaction
  379. (-) epigallocatechin gallate (EGCG) prevents lipid changes and collagen abnormalities in chronic ethanol-fed rats
  380. Difference in growth suppression and apoptosis induction of EGCG and EGC on human promyelocytic leukemia HL-60 cells
  381. Study on the protection mechanism of EGCG from ultraviolet B induced damage on cultured fibroblasts
  382. In vitro cytotoxicity of (-)-EGCG octaacetate on MDAMB-231 and SKHep-1 human carcinoma cells: A pharmacological consideration on prodrug design
  383. Protective effect of EGCG on experimental diabetic nephropathy in rats
  384. Topical application of green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) for prevention of recurrent oral neoplastic lesions
  385. EGCG inhibits recepteur d’origine nantais expression by suppressing Egr-1 in gastric cancer cells
  386. Therapeutic effect of epigallocatechin-3-gallate (EGCG) and silibinin on ATM dynamics in prostate cancer cell line LNCaP
  387. The green tea polyphenol, epigallocatechin-3-gallate (EGCG)—one step forward in antiviral therapy against hepatitis C Virus
  388. (−)-Epigallocatechin 3-gallate (EGCG) at the ocular surface inhibits corneal neovascularization
  389. The spectral properties of (-)-epigallocatechin 3-O-gallate (EGCG) fluorescence in different solvents: Dependence on solvent polarity
  390. A modulating effect of epigallocatechin gallate (EGCG), a tea catechin, on the bladder of rats exposed to water avoidance stress
  391. Optimization of lipase-catalyzed synthesis of acetylated EGCG by response surface methodology
  392. The protective effect of EGCG on INS-1 cell in the oxidative stress and mechanism
  393. Intra-peritoneal application of catechins and EGCG as in vivo inhibitors of ozone-induced oxidative stress
  394. Simultaneous Determination of EGCG, ECG and Caffeine in Green Teas by Thin Layer Chromatography Scanning [J]
  395. (-)-Epigallocatechin 3-O-gallate (EGCG)-induced apoptosis in normal rat kidney interstitial fibroblast (NRK-49F) cells
  396. EGCG ameliorates the suppression of long-term potentiation induced by ischemia at the Schaffer collateral-CA1 synapse in the rat
  397. Green tea EGCG suppresses specific antigen driven T cell response and affects CD4+ T cell differentiation
  398. Research Progress on Anticancer Effect of Epigallocatechin Gallate (EGCG)[J]
  399. Apoptotic effect of green tea polyphenol (EGCG) on cervical carcinoma cells
  400. The green tea catechin epigallocatechin gallate (EGCG) blocks cell motility, chemotaxis and development in Dictyostelium discoideum
  401. Inhibiting effects of epigallocatechin gallate (EGCG) on the formation of age pigment in vitro and in vivo
  402. Computational modeling of the potential interactions of the proteasome β5 subunit and catechol-Ο-methyltransferase-resistant EGCG analogs
  403. Molecular and thermodynamic basis for EGCG‐Keratin interaction‐part II: Experimental investigation
  404. Role of p38MAPKs pathway in the growth inhibition of rabbit lens epithelial cells induced by EGCG
  405. Synthesis of phosphates and phosphates–acetates hybrids of green tea polyphenol (−)-epigallocatechine-3-gallate (EGCG) and its G ring deoxy analogs as potential …
  406. Control of AMP-activated protein kinase, Akt, and mTOR in EGCG-treated HT-29 colon cancer cells
  407. Inactivation of prolyl hydroxylase domain (PHD) protein by epigallocatechin (EGCG) stabilizes hypoxia-inducible factor (HIF-1α) and induces hepcidin (Hamp) in rat …
  408. Vascular actions of the polyphenolic catechin gallate EGCG: endothelium-dependent contraction and relaxation
  409. The mechanism of synergistic antibacterial action between Ecg/EGCG and β-lactam antibiotics against MRSA [J]
  410. Efficient separation and purification of epigallocatechin gallate (EGCG) based on EGCG-imprinted polymer prepared with chitosan as matrix
  411. Production of Epigallocatechin Gallate 7‐ O‐α‐d‐Glucopyranoside (EGCG‐G1) Using the Glucosyltransferase from Leuconostoc mesenteroides
  412. Effect of Interactions Between EGCG and Zn~(2+) on the Growth of Prostate Cancer PC-3 Cells [J]
  413. Effects of topical application of EGCG on testosterone‐induced hair loss in a mouse model
  414. EGCG-meditated cyto-and genotoxicity in HaCat keratinocytes is impaired by cell-mediated clearance of auto-oxidation-derived H2O2: An algorithm for experimental …
  415. The study of chemotherapy sensitizing effect of EGCG on two multidrug resistant carcinoma cell lines
  416. The dietary supplement EGCG: NOPE (N-oleyl-phosphatidyletathanolamine and epigallocatechin-3-gallato formula) helps patients to follow a flexible dietary …
  417. The effects of EGCG and tq on inflammatory mediator production in raw 264.7 cells challenged with LPS-biomed 2010.
  418. Characteristics and Kinetics of Iron Releasefrom the Ferritin under the EGCG reduction
  419. Photoprotection of EGCG on HaCaT cells against oxidative damage and apoptosis from UVA irradiation
  420. Bioavailability of the green tea polyphenol,(-)-epigallocatechin-3-gallate (EGCG), in mice: dose-dependence and improvement via peracetylation
  421. Study on antioxidation with EGCG in the food system
  422. EGCG and Polyphenon E inhibit growth and activation of EGFR and HER2 signaling pathways in human colon cancer cells
  423. Determination of catechins in different tea polyphenols and comparison of EGCG isolation by column chromatography
  424. Effect of EGCG on expression of neurogenin 3 via the MAP kinase signaling pathway in AR42J cells, a rat pancreatic tumor cell line
  425. The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor
  426. Effect of tea polyphenols and EGCG on nasopharyngeal carcinoma cell proliferation and the mechanisms involved
  427. Induction of early apoptosis in human hepatocellular carcinoma cell line SMMC-7721 by epigallocatechin gallate (EGCG) and alteration of genomic and proteomic …
  428. Methylation of (-)-Epigallocatechin-3-gallate (EGCG)[J]
  429. EGCG: Potent extract of green tea
  430. Biological evidence for the benefit of green tea and EGCG in arthritis
  431. Synergistic pharmaceutical combinations for treating obesity with EGCG
  432. Green tea extract (GTE) is more effective than epigallocatechin gallate (EGCG) and epicatechin (EC) in inhibiting the lymphatic absorption of cholesterol (CH) and …
  433. Inhibitory Effects of Epigallocatechin Gallate (EGCG) and Cd~(2+) on the Growth of Prostate Cancer PC-3 Cell
  434. Expression of NF-κB and caspase-3 in nasopharyngeal carcinoma cell line in EGCG-mediated cell proliferation inhibition and apoptosis [J]
  435. Consumption of EGCG can become hepatotoxic under inflammatory condition
  436. Present studies and research prospects on the methylated EGCG.
  437. Gene expression spectra in human leukemia HL-60 cells treated with EGCG
  438. EGCG regulates TGF-β1-induced epithelial mesenchymal transition in squamous cell carcinoma of head and neck
  439. PROTECTIVE EFFECTS OF EGCG ON PARAQUAT-INDUCED INJURY IN PC12 CELLS [J]
  440. Study on properties of scavenging superoxide anion free radical with tea polyphenols (TP) compounds and L-EGCG.[J]
  441. EGCG depresses migration and invasion of human glioma cell line by downregulating COX-2 and MMP-2 expression [J]
  442. Study on the Influences of Microwave Pre-treatment on the Extraction Rate of Caffeine and EGCG from Green Tea with Supercritical-CO_2 Technology [J]
  443. Near Infrared Spectroscopy Determination of EGCG Content in Tea Based on OSC and PLS [J]
  444. Molecular and thermodynamic basis for EGCG‐Keratin interaction‐part I: Molecular dynamics simulations
  445. Study on Preparation of Acetylated EGCG [J]
  446. Curcumin inhibits pro-survival pathways in CLL B-cells and has the potential to overcome stromal protection of CLL B-cells in combination with EGCG
  447. Inhibitory effects of EGCG on telomerase activity of gastric carcinoma cells
  448. Oral Administration of EGCG, an Antioxidant Found in Green Tea, Inhibits Tumor Angiogenesis and Growth of Breast Cancer in Female Mice
  449. Influences of EGCG on Mitochondrial PTP Opening and Ca~ 2+ Transportation [J]
  450. A study of EGCG inhibiting cells’ proliferation in A549 cell line and its mechanism
  451. Inhibition of intestinal tumorigenesis in ApcMin/+ mice by (-)-epigallocatechin-3-gallate (EGCG),(-)-epicatechin-3-gallate (ECG), and Polyphenon E (PPE)
  452. Radiolabeling of EGCG with 131I and biodistribution in rats
  453. The protective effect of EGCG on hy-drogen peroxide induced SH-SY5Y cell injury
  454. Effects of (−)-epigallocatechin gallate (EGCG) on DNA strand breaks as evaluated by single-cell gel electrophoresis (SCG) in human lymphocytes
  455. Study on preparation process of high purity of epigallocatechin gallate (EGCG) by column chromatography [J]
  456. Regulation of Prostaglandin E2 (PGE2)-induced IL-6 production by Epigallocatechin-3-gallate (EGCG) in rheumatoid arthritis synovial fibroblasts
  457. Determination of content of EGCG and ECG in tea polyphenols by HPLC
  458. The Effect of (-)-Epigallocatechin Gallate (EGCG), Main Component of Green Tea, on Platelet Function [J]
  459. Effect Of (−)-epigallocatechin Gallate (EGCG), A Green Tea Extract, On Excitation-contraction Coupling Of Murine Cardiomyocytes
  460. Study on the fragmentation pathways of EGC/GC and EGCG/GCG using ESI–IT–TOF
  461. Free Radical Scavenging and Antilipoperoxidant Properties of EGCG [J]
  462. Isolation of genes related to EGCG content increasing by exogenous induction in tea shoots
  463. Biological significance of myeloperoxidase (MPO) on green tea component,(−)-epigallocatechin-3-gallate (EGCG)-induced apoptosis: its therapeutic potential for …
  464. Mechanism of apoptosis induction selective for cancer cells by EGCG
  465. Inhibitory effect of EGCG on proliferation and HIF-1α/VEGF expression in cell line HepG2
  466. Tumor Antipromoters: Sarcophytols A and B,(–)–Epigallocatechin Gallate (EGCG), and Morusin
  467. Research on the Extraction of EGCG from Tea Polyphenol [J]
  468. Curcumin and EGCG suppress apurinic/apyrimidinic endonuclease 1 and induce complete remission in B-cell non-Hodgkin’s lymphoma patients
  469. Cytoprotective effect of epigallocatechin gallate (EGCG) in oxidative-stressed PC12 cells following H2O2 exposure-effect of EGCG on phosphoinositide 3-kinase/Akt …
  470. Imaging Inhibition of Amyloid-Beta Protein Aggregation in Alzheimer’s Disease by Green Tea Epigallocatechin Gallate (EGCG)
  471. Kinetic Studies on Extraction of EGCG in [J]
  472. Inhibition effects of epigallocatechin-3-gallste (EGCG) on cell cycle of hum an breast cancer cells MDA-MB-435 and its mechanism
  473. The effects of TP and EGCG on the adherence and invasion of MDA-MB-231 human breast cancer cells
  474. Preventive Effects of EGCG on High Glucose Induced Podocyte Damage
  475. Synthesis of methylated EGCG and its stability in artificial simulation gastric juice and artificial simulation intestinal juice [J]
  476. Effects of EGCG on proliferation and differentiation of porcine preadipocytes
  477. Anti-obesity effect of EGCG on lipid metabolism and adipokines gene expression
  478. Anti-tumor activities of catechins EGCG and ECG against human hepatocarcinoma BEL-7402 cells
  479. Research Advances on Anticancer Activity of EGCG Abstracted from Tea
  480. The Protective Effects of EGCG Extracted from Green Tea on Apoptosis Induced by in Conjunctival Cell Lines
  481. Demethylation and transcription of p16 gene in malignant lymphoma cell line CA46 induced by EGCG
  482. Topical EGCG for treatment of dry eye disease
  483. Inhibitory Effect of EGCG on angiogenesis induced by multiple myeloma cell line KM3 and its mechanism
  484. Inhibitory effect of bortezomib on human multiple myeloma cells when combined with epigallocatechin-gallate (EGCG) analogs
  485. Effect of EGCG on H2O2-induced MnSOD gene expression in cultured spiral ganglion cells
  486. Study and Development of High-content EGCG Tea [J]
  487. Protective effects of epigallocatechin gallate (EGCG) against oxidative stress in cultured retinal pigment epithelial cells
  488. Effect of green tea and EGCG on the growth rate and cell density of the probiotic bacteria Lactobacillus acidophilus and Lactobacillus gasseri
  489. Study on the difference of EGCG content of teas in different regions
  490. Sensitization and mechanisms of EGCG on radiotherapy of nasopharyngeal carcinoma xenotransplanted tumor in nude mice [J]
  491. Effect and mechanism of EGCG on the proliferation and apoptosis of nasopharyngeal carcinoma cell line CNE-2 [J]
  492. Epigallocatechin Gallate (EGCG), a Green Tea Polyphenol, Reduces Expression of Endothelin-1 (ET-1) in Vascular Endothelial Cells by a FOXO-1-Dependent …
  493. Inhibitory effect of tea polyphenols and EGCG on cultured hypertrophic myocyte induced by Ang II
  494. Effect of Extraction Condition on the Content of EGCG and Caffeine of Green Tea: Comparison with the Inhibitory Activity on Pancreatic Lipase
  495. MDR-reversing effect of EGCG by decreasing expression of p-glycoprotein on human leukemic cell line
  496. EGCG inhibits critical pathways of signal transduction in human cancer cells.
  497. Research on reversal effect of multidrug resistance in human leukemic cell line by EGCG and its mechanisms [J]
  498. Study on the effect of anti-influenza virus of EGCG [J]
  499. Research of radioprotection of EGCG
  500. Effect of interactions between EGCG and Zn2+ on energy metabolism of PC-3 cells.
  501. Extraction and purification of polyphenolic compounds and determination of EGCG from eagle tea (Litsea coreana Lévi. var. lanuginosa).
  502. The Inhibitory Effects of EGCG on Proliferation of Human Gastr ic Cancer Cell Via Induction of Cell Cycle G1 Phase Arrest [J]
  503. Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and EGCG: the role of p53-dependent inhibition of nuclear factor …
  504. Effects of EGCG on proliferation and apoptosis of human gastric cancer cell line SGC7901 under hypoxia [J]
  505. Prostate specific membrane antigen (PSMA) targeting nano-EGCG for prostate cancer prevention and treatment.
  506. The anti-obesity effects of EGCG in relation to oxidative stress and air-pollution in China
  507. EGCG attenuates the inhibitory effect of high TNF-α level on the process of wound healing in dermal fibroblasts
  508. Green Tea Extract (EGCG) Inhibits Proliferation of Human Leiomyoma Cells.
  509. (−)-Epigallocatechin-3-Gallate (EGCG), Green Tea Component, Antagonize the Anti-Myeloma Activity of Proteasome Inhibitor PS-341 by Direct Chemical Interaction.
  510. Protective effect of EGCG on focal cerebral ischemia-reperfusion injury in rats
  511. Effects of EGCG on UV-induced IL-6 and NF-κB from Human Keratinocytes in Vitro [J]
  512. Adsorption Separation of (-)-Epigallocatechin-3-Gallate (EGCG) and Caffeine by Resin RB [J]
  513. EGCG and 4-hydroxytamoxifen synergistically induce cytotoxicity in MDA-MB-231 human breast cancer cells: The role of apoptosis and signaling proteins
  514. Research progress on biological activity of epigallocatechin-3-gallate (EGCG)
  515. The highly effecitive methods for extracting EGCG from fresh tea [J]
  516. Induction of apoptosis in human gastric cancer cell line by EGCG
  517. Preparation of PLGA microparticles by a double emulsion solvent technique for sustained release of (-)-epigallocatechin gallate (EGCG) and their growth inhibitory …
  518. In vitro studies for evaluation the antitumoral and immunomodulator effect of EGCG on Ehrlich Ascites
  519. Optimization on the Isolating and Purifying Technologies of EGCG from Tea Polyphenols [J]
  520. Research progress on the protective effect of EGCG on Alzheimer’s disease
  521. Comparsion of Varicol and partial-discard process with traditional process to purify ECG and EGCG from green tea polyphenols using simulated moving bed …
  522. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol suppresses bacilli-induced augmented expression of Mycobacterium tuberculosis 85B and …
  523. Comsposition for stablizing epigallocatechin gallate (EGCG) in water phase and preparation method thereof
  524. Biochemical and histological evaluations of articular cartilages preserved in cold storage solution containing green tea catechin, EGCG
  525. Docking Studies on Transcription Factor sp1: The Transcriptional Down-Regulation of TACO Gene by EGCG and the Importance of TACO in M. tuberculosis …
  526. Attenuation of cardiac oxidative stress by (À)-epigallocatechin-gallate (EGCG) in CS exposed rats
  527. Stability of (-)-epigallocatechin gallate (EGCG) in a strawberry sorbet.
  528. Inhibitory effect of EGCG on apoptosis of Langerhans cells after UVB irradiation
  529. Changes of Caspase-3 Activity and mRNA in EGCG induced apoptotic Hep-G2 cells
  530. Dietary supplementation with green tea EGCG at high dose promotes inflammatory response
  531. Secrets of Epigallocatechin-3-Gallate (EGCG) in Green Tea
  532. Study on the effect of EGCG-induced apoptosis in squamous cell carcinoma of the head and neck [J]
  533. EGCG Promoting Apoptosis of Human Prostate Cancer Cell PC-3 and Its Influence on Expressions of Survivin Protein
  534. Effect of L-EGCG on lipopolysaccharide-induced glomerular mesangial cell proliferation in rats
  535. Effect of EGCG on the proliferation and invasion of human hepatoma HepG2 cells
  536. EGCG inhibit rabbit lens epithelial cell growth by regulating PKB phosphorylation
  537. Preparation and Physico-chemical Characterization of EGCG-phospholipid Complex [J]
  538. Inhibition of amyloid β peptide-induced neuronal cytotoxicity by EGCG
  539. 156 PRETREATMENT WITH THE ANTIOXIDANT EPIGALLOCATECHIN GALLATE (EGCG) COUNTERACTS THE NEGATIVE EFFECTS OF MATERNAL …
  540. Effect of EGCG on the expression and activity of P-glycoprotein in breast cancer cells.
  541. Epigallocatechin‐gallate (EGCG) inhibits VEGF‐induced angiogenesis by suppressing receptor complex formation, PI3‐kinase activity and production of IL‐8 via NF …
  542. Green tea catechin EGCG suppresses T cell-mediated function through inhibiting cell division and reducing cell survival
  543. Neuroprotective Effect of Green Tea Polyphenol, EGCG in Animal Model of Parkinson’s Disease
  544. Oral Administration of EGCG, a Green Tea Antioxidant, Reduces Growth and Capillary Density of Melanoma but does not affect those of the Heart and Skeletal …
  545. Degradation and metabolism of catechin, epigallocatechin-3-gallate (EGCG), and related compounds by the intestinal microbiota in the pig cecum model.
  546. Effects of EGCG on the nasopharyngeal carcinoma cell line CNE-2 and the expression of related gene
  547. Effect of EGCG on proliferation of prostate cancer PC-3 cells [J]
  548. Effect of EGCG on ethology and expression of Bax and Bcl-2 in vascular dementia rats
  549. Effect of EGCG on invasion of breast cancer cells and its possible mechanism
  550. Growth of smooth muscle cell and endothelial cell on PLGA film containing EGCG
  551. The green tea polyphenol EGCG induces Mesenchymal to Epithelial Transition (MET) and tumor regression in Triple Negative Breast Cancer (TNBC) cells and mouse …
  552. Mechanisms involved in inhibitory action of EGCG against intestinal tumorignesis in ApcMin mice
  553. Mechanism by which EGCG inhibits proliferation of collagen Ⅱ-specific T cells
  554. Suppression of Wnt signaling by the green tea compound EGCG in breast cancer and the requirement for the HBP1 transcriptional repressor
  555. Effect of EGCG on apoptosis of cervical cancer Hela cells induced by DDPand the related mechanism of tumor cell apoptosis [J]
  556. EGCG and nimodipine improve the symptoms of AD by inhibiting [Ca2+] i in hippocampal neurons of APP/PS1 transgenic mice
  557. Blocking and suppressing effects of white tea, green tea, EGCG and caffeine in PhIP-treated rats
  558. The role of reactive oxygen species in (-)-epigallocatechin-3-gallate (EGCG)-induced cell growth inhibition and apoptosis in oral cancer cells
  559. Differential regulation of genes for intestinal cholesterol flux by epigallocatechin gallate (EGCG) and resveratrol (RES) in Caco-2 cells: Potential role of histone …
  560. The effects of (−)-epigallocatechin-3-gallate (EGCG) and phosphatidylinositol 3-kinase (PI (3) K) inhibition on Burkitt lymphoma cells
  561. Synergistic anticancer activity of EGCG with cancer preventive agents mediated through GADD153 gene expression in human lung cancer cells
  562. Constitutive overexpression of Nrf2-dependent HO-1 confers resistance to apoptosis by EGCG in human lung adenocarcinoma A549 cells
  563. EGCG Protects Cultured Spiral Ganglion Cells from H_2O_2-induced Damage [J]
  564. Effects of EGCG on the proliferation and apoptosis of human oral squamous cell carcinoma Tca8113 cell line
  565. Effects of EGCG on hair growth of C57BL6 mouse alopecia model [J]
  566. Effect of EGCG on apoptosis and mutation of human skin fibroblasts damaged from long-term ultraviolet radiation
  567. Effects of EGCG on Renal Oxidation in Streptozotocin-induced Diabetic Rats [J]
  568. Fatty acid metabolism in cancer cells: Differential inhibitory effects of epigallocatechin (EGCG) and C75
  569. The Mechanism of Anti-angiogenesis in Leukemia by (-)-Epigallocatechin Gallate (EGCG), Main Component of Green Tea
  570. Extraction and Purification of Tea Polyphenols and EGCG
  571. Protection Effect of EGCG on the immune function of dendritic cells after UVB irradiation [J]
  572. In vivo evaluation of EGCG stabilized gold-198 nanoparticles in prostate cancer bearing mice
  573. ROLE OF (-)-EPIGALLOCATECHIN GALLATE (EGCG) AGAINST OXIDATIVE IMPAIRMENTS INDUCED IN GAMMA IRRADIATED RATS: BIOCHEMICAL …
  574. Selective adsorption and separation of (−)-epigallocatechin gallate (EGCG) based on silica gel surface molecularly imprinted polymers
  575. Pretreatment technology Study On Simulated Moving Bed Chromatography (SMBC) Separation Epigallocatechin Gallate (EGCG)[J]
  576. Synergistic apoptosis by combination of natural compound EGCG and resveratrol in head and neck cancer: Potential role for AKT-dependent signaling
  577. The inhibitory action of EGCG on the proliferation in the triple-negative breast cancer cell MDA-MB-231 and its mechanism [J]
  578. EGCG Regulates Mucin by p38 MAPK/MMP-9 Pathway in Asthma
  579. EGCG effect on the expression of Bcl-2/Bax in spiral ganglion neuron of the rat induced by Amikacin []
  580. The role of Nrf2 in the expression of UGT1A and its isoforms induced by EGCG in colon tumor [J]
  581. The roles of caveolin-1 and heme oxygenase-1 in EGCG-mediated protection against TNF-α-induced endothelial inflammation
  582. Study on the Protective Effect of EGCG Against the Cytotoxicity Induced by Topical Anesthetic Proparacaine Hydrochloride
  583. P3. 41 In vivo studies on the effects of EGCG, a major polyphenol in green tea, on a mouse model of Duchenne muscular dystrophy
  584. EGCG prevents the loss of pontine noradrenergic neurons induced by diabetes: a role in diabetic neuropathic pain
  585. Preparation, Characterization, and In Vitro Evaluation of EGCG-Loaded Chitosan Nanoparticles
  586. Study on Preparation Process of Effervescent Tablets Made from EGCG of Tea.
  587. Effects of UVB irradiation on protein expressions of XPA and ERCC1 in human primary keratinocytes and intervention of EGCG [J]
  588. EGCG inhibits wnt/β-catenin signaling pathway to regulate proliferation and differentiation of satellite cells in porcine skeletal muscle
  589. EGCG effect on in-vitro culture of mouse oocytes
  590. Advances on EGCG and Wnt Signal Pathways of Malignant Cells [J]
  591. Kinetics Study on EGCG Changes During Thermal Processing [J]
  592. Effects of EGCG on the Expression of Connexin43 and Gap Junction Intercellular Communication of the Bladder Cancer Cell Line BIU-87
  593. DPPH Scavenging Activity and Total Antioxidant Activity of Methylated EGCG Derivatives [J]
  594. Preparation and Characterization of EGCG Molecularly Imprinted Chitosan Membrane [J]
  595. Toxicity Study of 3-Epigallocatequin Gallate (EGCG) In An Animal Model
  596. Epigallocatechin-3-gallate (EGCG) disrupts VEGF receptor-HIF (hypoxia inducible factor-1α) association: Implications for down-regulation of VEGF production and the …
  597. THE EFFECT OF CELL APOPTOSIS OF EGCG ON RENAL ISCHEMIA-REPERFUSION [J]
  598. Determination of EGCG in lvcha xueha tablets by HPLC [J]
  599. INHIBITION EFFECT OF L-EGCG ON CIGARETTE SMOKE-INDUCED DAMAGE TO RAT LUNG CELLS [J]
  600. Enhancing glutaminolysis in glutamine dependent breast cancer cells with TRO provides a therapeutic window for GDH inhibition by EGCG inducing massive cell …
  601. Cancer Prevention by Green Tea via EGCG-Mediated Inhibition of Fatty Acid Synthase
  602. Effect of Epigaloctechin-3-gallit (EGCG) on the Release of Inflammatory Cytokines and Expression of Neurotrophic Factors in Spinal Cord-injuried Rats [J]
  603. The Cancer Preventive Potential of Tea Polyphenol EGCG in HER2-Positive Breast Cancer
  604. STUDY ON PREPARATION PROCESS OF HIGH PURITY OF TEA CATECHINS EGCG FROM TEA POLYPHENOLS [J]
  605. Effect on Arterial Col Ⅰ, Col Ⅳ, FN Expression of a Model for Type 2 Diabetes after Exercise and Oral EGCG and Possible Mechanism [J]
  606. Study on Screening Tea Resources with High EGCG from Sichuan [J]
  607. DPPH Radical Scavenging Capacity by EGCG, EGCG4 ″Me and EGCG3 ″Me [J]
  608. … -blind, randomized-controlled trial of a nutritional supplement (abs+) containing conjugated linoleic acid (CLA) and epigallocatechin-gallate (EGCG) in human weight …
  609. A critical evaluation of the information and data submitted on the safety of EGCG, Epigallocatechin gallate (TEAVIGOTM)
  610. Super antioxidant from the sea: more potent than EGCG from green tea
  611. Composition containing ginsenoside f1 and EGCG for preventing skin damage
  612. Molecular targets of green tea catechin, EGCG, on human colorectal carcinogenesis
  613. GREEN TEA POLYPHENOL EGCG-INDUCED CELL DEATH PATHWAY THROUGH THE 67kDa LAMININ RECEPTOR
  614. Identification of The Molecules and Mode of Action Involved In The Melanoma Inhibitory Effect of Green Tea Polyphenol EGCG
  615. Radiation protection effects of EGCG on HaCat cells of human skin
  616. Effects of green tea epigallocatechin-3-gallate (EGCG) on the formation of mineralized bone nodules by human osteoblast-like cells.
  617. DOWNREGULATION OF THE IDGH-AFFINITY IgE RECEPTOR EXPRESSION ON MAST CELLS BY GREEN TEA CATECHIN EGCG
  618. EGCG Sensitisizes Cisplatin-resistant Human Lung Adenocarcinoma Cells A549/DDP to Cisplatin
  619. Intervention of EGCG on Cell Senescence and Chronic Photodamage in Human Skin Fibroblasts
  620. Effect of EGCG on hippocampal neurogenesis and synaptic density in Alzheimer’s disease mice
  621. II-5. Inhibitory effects of green tea polyphenol (-)-epigalloca-techin (EGCG) on the MMP expression and the osteoclast survival
  622. Interaction Of EGCG Molecules With Silver‐Lysozyme Complex By SERS Measurements
  623. Inhibitory effect of EGCG on proliferation and HIF-1?/VEGF expression in cell line HepG2
  624. Effects of EGCG on BGC-823 gastric cancer cell proliferation and VEGF expression
  625. Investigation of EGCG distribution in HUVECs
  626. Epigallocatechin gallate (EGCG)-loaded nanoparticles decrease cholesterol content in THP-1 derived macrophages
  627. Effects and mechanism of EGCG on human prostate cancer xenografted tumor growth and connexin43 expression in nude mice
  628. Interaction of ctDNA and EGCG-Cu (II) complex
  629. Optimization of the extraction technology of EGCG from green tea
  630. Modulation of endothelial cell gene expressions by green tea epigallocatechin gallate (EGCG)
  631. Neuroprotective effects of EGCG on H2O2-and MPTP-stressed PC12 cells
  632. Phosphodiesterase V selective inhibitor enhances pro-apoptotic effect of EGCG by enforcing EGCG signaling pathway through the 67 LR
  633. EGCG
  634. Effect of the disequilibrium of calcium homeostasis on apoptosis induced by EGCG in human BGC-823 gastric cancer cells
  635. Effects of EGCG on Cell Cycle Arrest by Regulating NF-κB Entering the Nucleus
  636. Mechanisms of Asthma: 118 EGCG Downregulates Mucin Gene Expression Through the Mapk Signaling Pathway in Asthma
  637. Green tea EGCG suppresses T cell proliferation by impairing IL-2/IL-2R signaling leading to inhibition of cell cycle
  638. Cell cycle arrest and apoptosis induction in human prostate cancer cell lines (PC-346C, LNCaP and PC-3) by the green tea ingredient EGCG (Epigallocatechingallate …
  639. Effect of green tea EGCG on T cell function and the mechanisms
  640. A RECEPTOR FOR EPIGALLOCATECHIN-3-0-GALLATE: 67 kDa LAMININ RECEPTOR MEDIATES ANTICANCER ACTION OF EGCG
  641. Inhibitory role of EGCG on proliferation of rabbit lens epithelial cells
  642. The Anti-Cancer Effect A Green Tea Polyphenol (EGCG) Alone Or In Combination With Chemotherapy Or Radiotherapy On Tongue Carcinoma Cells In Culture.
  643. Study on Effects of EGCG on Experimental Focal Brain Ischemia Injury in Rats
  644. Changes of cell cycle regulatory proteins expression by EGCG in ovarian cancer cells
  645. Neuroprotective Effects of EGCG against Amyloid-beta (1-42)-Induced Apoptosis
  646. The Inhibitory Effect and Mechanism of Ester Catechin Monomers-EGCG, GCG on the Growth of Human Colon Carcinoma Cell Line SW480
  647. Effect of in vitro supplementation with tea catechin, epigallocatechin-3-gallate (EGCG), on T cell mediated immune response
  648. Inhibitory effect of intrathecal EGCG on mechanical allodynia and nitric oxide synthase expression in spinal cord in neuropathic pain of rat: 7AP3-3
  649. Effects of Green Tea and EGCG on IL-8 and NF-κB Inflammatory Responses in LPS-Induced, Fully Differentiated HT-29 Human Colon Cancer Cells
  650. EGCG Inhibits Inflammation Independently of AMPK (87.10)
  651. Dietary Epigallocatechin-3-gallate (EGCG) supplementation reduces clinical symptoms and pathology associated with experimental autoimmune encephalomyelitis …
  652. EGCG protects against 6-OHDA induced neurotoxicity in a cell culture model
  653. INDUCTION OF APOPTOSIS IN VITRO USING EPIGALLOCATECHIN-3-GALLATE (EGCG) IN SELECTED TUMOUR CELLS
  654. Research of radioprotection of EGCG
  655. A new technology of preparation for EGCG
  656. Effect of EGCG on cell cycle, apoptosis and Lipid production in SEB-1 sebocytes
  657. Effects of EGCG on human esophageal squamous cell carcinoma cell line KYSE 150 in the presence and absence of superoxide dismutase
  658. Effects of EGCG on apoptosis of human bladder carcinoma T24 cells
  659. EGCG-A CONSTITUENT OF GREEN TEA-INHIBITS CHONDROCYTE APOPTOSIS
  660. EFFECT OF EGCG ON THE GROWTH INHIBITION AND APOPTOSIS OF HUMAN ORAL SQUAMOUS CELL CARCIONMA TCA8113
  661. STUDY ON THE NEUROPROTECTIVE EFFECT OF EGCG ON HIPPOCAMPAL NEURONS UNDER STRESS IN VITRO AND ITS MECHANISM
  662. Abstract B47: EGCG induces apoptosis and inhibits proliferation of nasopharyngeal carcinoma cells in vitro and in vivo.
  663. Radioiodine-labeling of EGCG and its biodistribution in mice
  664. Abstract# 3919: EGCG inhibits Hsp90 function by impairing Hsp90 association with cochaperones in pancreatic cancer cells
  665. Regulation of EGCG on Expression of COX-2, VEGF, and bFGF in Nude Mice Xenogrfts Tumor of Human HepG2 Cells [J]
  666. Linking the pro-oxidant influences of epigallocatechin gallate (EGCG) to intestinal cholesterol metabolism via alterations in sirtuin 1 (SIRT1) using Caco-2 cells
  667. Influence of EGCG on cellular functions of dendritic cells after UVB irradistion
  668. Modulation of apoptosis and the production of reactive oxygen species in human neutrophils with epigallocatechin-3-gallate (EGCG)(101.6)
  669. DIMINISHED EGCG-MEDIATED APOPTOSIS IN THE DIFFERENTIATED HL-60CELLS
  670. Site Specific Interaction of the Polyphenol EGCG with the SEVI Amyloid Precursor Peptide PAP (248â 286)
  671. MOLECULAR MECHANISM OF EGCG INHIBITION OF ANGIOGENESIS
  672. Epigallocatechin-3-gallate (EGCG) inhibits IL-1β-induced chemokine production and MMP-2 activation in rheumatoid arthritis synovial fibroblasts in vitro
  673. Study on the Growth Inhibition of Plasmodium f alciparum in Vitro of (-)-Epigallocatechin Gallate (EGCG)
  674. Effect of epigallocatechin-3-gallate (EGCG) on the expressions of nuclear faclor-E2 related factor2 (Nrf2) and γ-glutamylcystein synthase (γ-GCS) in renal tubular …
  675. (-)-Epigallocatechin-3-O-Gallate (EGCG) inhibits apoptosis induced by ionizing radiation in keratinocytes
  676. EGCG Induce Internalization of Epidermal Growth Factor Receptors (EGFR)
  677. Involvement of AMPK in the regulation of CSK, COX-2 and mTOR in cancer cell growth control under EGCG treatment
  678. Effect of green tea polyphenol EGCG on COX-2 expression in human colon cancer cells
  679. Dietary (−)-epigallocatechin-3-gallate (EGCG) inhibits expression of hepatic lipogenic enzymes in C57BL/6J obese mice
  680. Changes of cell cycle regulatory proteins expression by EGCG in ovarian cancer cells.
  681. Computational modeling and biological evaluation of methylated (-)-EGCG analogs
  682. Model Organisms and Disease; Phosphathdylinositol-3 kinase and glycogen synthase kinase mediated neuroprotective action of EGCG against quinolinic arid …
  683. Inhibition of intestinal tumorigenesis in ApcMin/+ mice by a combination of (-)-epigallocatechin-3-gallate (EGCG) with fish oil or calcium
  684. Interventional Effect of EGCG on Transdifferentiation of Renal Tubular Epithelial Cells in Rats with Obstructive Nephropathy and Its Mechanism
  685. Study of EGCG Inhibited Proliferation of HL-60 Cells
  686. EGCG-Mediated Sirt1 Activation Prevents Prion-Mediated Neurotoxicity Through Autophagic Pathway.
  687. Effects of L-EGCG on proliferation glomerular mesangial cells of rat model induced by lipoprotein (a).[J]
  688. Effect of epigallocatechin gallate (EGCG) and Ni~(2+) on the expression of cyclinD1 and survivin genes in tongue squamous carcinoma cells
  689. The effect of PUMA on EGCG-regulated growth of human hepatoma carcinoma cell
  690. Inhibitory effect of EGCG on the expression of TGF-β1 and Smad4 in PLA-802 cells
  691. Influence of green tea extractive EGCG on apoptosis of human tongue carcinoma Tca8113 cells
  692. EGCG reduces Ang II-induced NAD (P) H oxidase and NO synthase expression in HUVECs
  693. Epigallocatechin-3-gallate (EGCG) inhibits IL-1β-induced IL-6 production and cyclooxygenase-2 (COX-2) expression in rheumatoid arthritis synovial fibroblasts in vitro
  694. Green tea polyphenol EGCG upregulates mir-210 expression in lung cancer cells by transiently stabilizing HIF1α
  695. EGCG suppresses CD3-mediated T-cell-induced pathways in leukemia cells via Zap-70 inhibition
  696. Cancer Biology; Anti-oxidative and apoptosis-inducing activities of EGCG
  697. Abstract A178: Epigallocatechin-3-gallate (EGCG) induces catalase-sensitive cell growth inhibition and AKT activation in Burkitt lymphoma cells.
  698. Differential Effects of EGCG, a Green Tea Antioxidant, on Vascular Endothelial Growth Factor (VEGF) Expression and Proliferation in Cultured ER-positive and ER …
  699. Abstract# 2461: Modeling of the interaction between EGCG and two separate kinase domains of RSK2
  700. Mechanisms of EGCG inhibiting the proliferation of human colon cancer HT-29 cells and preventing angiogenesis
  701. EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-induced apoptosis
  702. The inhibitory effects of (-)-Epigallocatechin Gallate (EGCG) on epidermal growth factor receptor (EGFR) activity are associated with changes in membrane domain …
  703. Photodynamic therapy in combination with green tea polyphenol including EGCG enhances antitumor efficacy in human papillomavirus 16 (E6/E7) immortalized tumor …
  704. Chronic administration of low dose EGCG inhibits TNF-α-induced IL-6 and IL-8 production in rheumatoid arthritis synovial fibroblasts
  705. … and Prostaglandin E2 production in Chondrocytes are Inhibited by the Combination of Avocado Soy Unsaponifiables (ASU) and Epigallocatechin gallate (EGCG)
  706. Abstract B74: EGCG inhibits cancer invasion by regulating tumor-stromal crosstalk in oral squamous cell carcinoma
  707. Preventive effects of EGCG on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice
  708. Effect of green tea extractive, EGCG, on ultrastructure of HepG2 transplanted tumor in nude mice
  709. c-Src plays a role in internalization of epidermal growth factor receptors (EGFR) induced by (-)-epigallocatechin gallate (EGCG) in SW480 colon cancer cells.
  710. EGCG inhibits activation of the IGF/IGF-1R system in human colon cancer and hepatoma cells
  711. EGCG upregulates phase-2 detoxifying and antioxidant enzymes via the Nrf2 signaling pathway in human breast epithelial cells
  712. Inhibition of intestinal tumorigenesis in ApcMin mice by (–)-epigallocatechin-3-gallate (EGCG): Possible mechanisms involved.
  713. Inhibitory effects of green tea and a constituent of green tea, epigallocatechin-3-gallate (EGCG) on nitric oxide production in macrophages
  714. EGCG inhibits pancreatic cancer growth in xenografts and KrasG12D transgenic mice models
  715. EGCG inhibits pancreatic cancer growth and stem cell characteristics in xenografts and KrasG12D transgenic mice models
  716. Green tea polyphenol EGCG antagonizes androgen function: Novel insight into the mechanism of chemopreventive effects of green tea on prostate cancer
  717. Effect of EGCG on SGC-7901 cells migration and metastasis
  718. Original Paper: Biochemical and Histological Evaluations of Articular Cartilages Preserved in Cold Storage Solution Containing Green Tea Catechin, EGCG
  719. Abstract# 4508: Green tea polyphenol EGCG blunts nuclear shuttling of androgen receptor: novel insight into its androgen antagonistic function in prostate cancer
  720. Inhibitive effect of EGCG on MCF-7 cell migration and invasion
  721. Epigallocatechin gallate (EGCG) causes antiproliferation and induction of apoptosis of Ewing sarcoma tumor cells through the inhibition of IGF-1R
  722. Clinically used nitrocatechols and EGCG synergistically inhibit lung cancer cells in vitro
  723. Effects of Green Tea and EGCG on IL-8 Inflammatory Responses in LPS and TNF-α-Induced, Differentiated HT-29 Human Colon Cancer Cells
  724. p21-mediated cell cycle arrest predominates and protects colon cancer cells from p53-dependent apoptosis by EGCG
  725. EGCG Exerts Antioxidant Protection in Unilateral Testicular Torsion
  726. EGCG prevents hepatocellular carcinoma development in a diethylnitrosamine-induced rat model
  727. TP 2.11 Comparison of subcutaneous injection and oral routes of administration of EGCG for ameliorating dystrophic lesions in a mouse model of Duchenne muscular …
  728. EGCG suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the VEGF/VEGFR axis
  729. Effects of EGCG on migration and invasion and FoxM1 expression of human gastric cancer cell
  730. Effects of EGCG on activation of the IGF/IGF-1R system in human hepatoma cells
  731. Effects of topical application of EGCG on testosterone induced hair Loss in mouse model (초)
  732. Lipids Free Radicals Produced by Myocardial Mitochondria During Lipid Peroxidation and the Inhibitory Effect of (–)-EGCG.
  733. Effect of EGCG on Methylation and Expression of RASSF1A in Ovarian Cancer Cell Line A2780
  734. Reversed-phase HPLC with Photo-diode Array Detection of the Oxidation Products from (-)-ECG,(-)-EGCG and Black Tea Liquor
  735. Investigation of the in vitro metabolism of EGCG and acetaminophen by rat liver microsomes
  736. Determination of Human Plasma Protein Binding of EGCG by Ultrafiltration
  737. Effects of EGCG on the Expression of CTGF in HK-2 Cells
  738. Experimental Study on EGCG Reversing the Multidrug Resistance of Esophageal Cancer Cell Line Eca109/DDP
  739. Effects of EGCG on the proliferation and apoptosis and the expression of stat3 in BEL-7402 cells
  740. EGCG inhibits pancreatic cancer stem cell characteristics in human primary tumors, and carcinogenesis in KrasG12D transgenic mice.
  741. (-)-Epigallocatechin Gallate (EGCG) causes internalization of the epidermal growth factor receptors (EGFR) in SW480 colon cancer cells.
  742. Chemopreventive effects of EGCG and Polyphenon E on inflammation-related mouse colon carcinogenesis induced by AOM and DSS
  743. Molecular mechanism of cytotoxic synergism induced by arsenic trioxide and EGCG
  744. Mandibular and Neural Crest Cell Deficits Seen in TsDn65 Down Syndrome Mouse Model Rescued By Green Tea Polyphenol, EGCG
  745. Abstract# 2373: Green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) induced oxidative stress and DNA damage in cancer cell lines and xenograft tumors
  746. Effect of EGCG on Mesangial Cells Proliferation Cultured Condition and Expression of Cyclin Kinase Inhibitor p27 in High Glucose
  747. EGCG suppresses tumor growth by inhibiting activation of the VEGF/VEGFR axis in the xenograft model of human colon cancer and hepatoma
  748. Suppression of cigarette smoke condensate-induced NFκB activation in normal human bronchial cells by green tea polyphenol EGCG
  749. EGCG suppresses obesity-related colonic preneoplastic lesions in C57BL/KsJ-db/db mice
  750. 210 GREEN TEA POLYPHENOL EPIGALLOCATECHIN-3-GALLATE (EGCG) INHIBITS ADVANCED GLYCATION END PRODUCTS-INDUCED EXPRESSION …
  751. Effect of the green tea polyphenol epigallocatechin gallate (EGCG) on growth and IL-6 signalling pathways in malignant plasma cells
  752. EGCG suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice
  753. Imprinted CS Membrane Using EGCG As Template
  754. EGCG inhibits growth of human pancreatic tumors orthotopically implanted in BALB/c Nude mice through activation of FKHRL1/FOXO3a transcription factor.
  755. Green tea derived catechin EGCG decreases peripheral blood endothelial lineage cells in tumor bearing mice
  756. Interactions between EGCG and SERMs in a xenograft model of ERα-breast cancer.
  757. Optimization of Preparation Condition for High Active EGCG Oxidation Products
  758. Pilot study of anti-erosive effect of green tea extractive EGCG on dentine
  759. Abstract A54: Epigenetic changes in colon cancer cell lines treated with the tea polyphenolic, EGCG
  760. Synergistic effect of green tea EGCG treatment with gamma radiation in leukemia cell necrosis
  761. Abstract# 2369: Effects of epigallocatechin gallate (EGCG) on UV radiation-induced lipid peroxidation products in skin cancer models.
  762. Hepatocyte growth factor induced prostate tumor cell scattering, motility and invasion is blocked by the green tea polyphenol, EGCG
  763. Epigallocatechin-3-gallate (EGCG) down-regulates the androgen receptor and the IGF pathway in the prostate of TRAMP mice
  764. GREEN TEA POLYPHENOL EGCG SIGNALLING THROUGH THE 67-kDa LAMININ RECEPTOR
  765. EGCG inhibits ephrin A1 mediated endothelial migration
  766. EGCG inhibits activation of the EGFR, HER2, and HER3 signaling pathways and inhibits expression of COX-2 in human colon cancer cells
  767. Abstract# 5079: Functional and genomic response of human renal cell cancer (RCC) to epigallocatechin 3-gallate (EGCG).
  768. Response of lymph node and organ metastasized melanoma cells to green tea catechins (EGCG, EGC & ECG) differs markedly from that of prostate and epithelial …
  769. Effects of acute exercise and epigallocatechin gallate (EGCG) incubation on mouse skeletal muscle Nampt levels
  770. CHARACTERIZATION OF EGCG COMPOUND USE H NMR SPECTRUM ON CAMELLIA SINENSIS (L.) CALLUS
  771. The Effect of (-)-Epigallocatechin Gallate (EGCG) on the Corrosion Behavior of NiCr Dental Casting Alloys
  772. EPIGALLOCATECHIN-3-GALLATE (EGCG) INHIBITS THE INFLAMMATORY EFFECTS OF IL-1 BETA IN HUMAN CHONDROCYTES
  773. Abstract B68: EGCG and theaflavin are direct inhibitors of the oncogenic lipid kinase, sphingosine kinase 1
  774. The homology model of glucose-regulated protein 78 (GRP78) for the docking of (-)-epigallocatechin-3-gallate (EGCG) molecule into ATP binding site
  775. P3-17-07: EGCG, a Green Tea Antioxidant Suppresses Breast Tumor Angiogenesis and Growth Via Inhibiting the Activation of HIF-1a and NFκB, and VEGF …
  776. EGCG enhances the therapeutic potential of gemcitabine and CP690550 (Tasocitinib) by inhibiting STAT3 signaling pathway in human pancreatic cancer cells
  777. Combination of 4-HPR and EGCG induces apoptosis and inhibits angiogenesis and tumorigenesis of neuroblastoma SH-SY5Y and SK-N-DZ cells
  778. Abstract A39: EGCG, a green tea polyphenol, can reverse methylation related silencing of genes in human colon carcinomas
  779. Epigallocatechin 3-gallate (EGCG) as a natural product (NP) with potent antitumor activity against human ovarian cancer
  780. EGCG sensitizes human prostate cancer LNCaP cells to TRAIL induced apoptosis through modulation of extrinsic and intrinsic pathways and synergistically inhibits …
  781. Studies of apoptotic signaling pathway in human cancer cells by (-) EGCG of green tea.
  782. Synergistic tumor growth inhibition by combined treatment with green tea epigallocatechin-3-gallate (EGCG) and an epidermal growth factor receptor (EGFR) tyrosine …
  783. Abstract A40: Epigenetic modification of human colon cancer by the green tea polyphenol EGCG
  784. Differential MAPK-responsive Protection against Oxidized LDL-induced Endothelial Apoptosis by Epigallocatechin gallate (EGCG), Quercetin and Hesperetin
  785. Anti-oxidative and anti-proliferative effect of (-)-epigallocatechin gallate (EGCG)
  786. RESTORATION OF ANTIBACTERIAL ACTIVITY OF~-LACTAMSBY EGCG DEPENDING ON LOCATIONS OF~-LACTAMASES
  787. Apoptotic effects of EGCG via AMPK/mTOR pathway and AMPK/CSK signaling on HT-29 colon cancer cells and HepG2 hepato-carcinoma cells
  788. Effects of EGCG on proliferation of Th17 cell and inflammatory factors in vitro [J]
  789. The Protection of EGCG from Amikacin-induced Apoptosis of Spiral Ganglion Neurons in Rats
  790. Abstract# 5520: Effect of Epigallocatechin 3-gallate (EGCG) and cancer chemotherapy on in vitro proliferation of chemoresistant, A375 human malignant melanoma
  791. Effects of EGCG on Focal Cerebral Ischemia-Reperfusion Injury in Rats
  792. Inhibition of Cyclooxygenase-2 expression and Prostaglandin E2 production in Chondrocytes by Curcumin and Epigallocatechin gallate (EGCG)
  793. The effect of green tea extractive EGCG on the proliferation ability and apoptosis of human hepatoma carcinoma cell line
  794. Abstract A194: Epigenetic modification of RXRα in human colon carcinomas by the green tea polyphenol, EGCG
  795. Effects of EGCG on expression of MMP9 and cyclin D1 in the transdifferentiation of renal tubular epithelial cell and its significance
  796. Effect of Epigallocatechin Gallate (EGCG), Resveratrol, and Curcumin on Proliferation and Apoptosis of Human Pigment Epithelial Cells
  797. Effects of resveratrol, epigallocatechine gallate (EGCG) and curcumin on the proliferation of human retinal endothelial cells in vitro
  798. Whole genome survey for epigenetic changes in response to EGCG treatment in lung cancer cells
  799. Anti-aging Effects of an EGCG Containing Product on Facial Skin in Females
  800. Abstract B63: Unraveling the paradoxes of ATM resensitized dynamics in LNCaP cell line via epigallocatechin-3-gallate (EGCG)
  801. Inhibition effect of tea polyphenols and single L-EGCG on lipid pefoxidation.
  802. Analysis of the effects of epigallocatechin-3-gallate (EGCG) of Camellia sinensis (green tea) in experimental chemical model of hepatotoxicity induced by …
  803. Theanine, EGCG and caffeine determinated by HPLC
  804. EGCG Mediated Transcriptional Regulation of zf9 as a Key Nuclear Factor of Liver Cirrhosis
  805. Purification of EGCG monomer from the extracts of tea by high speed countercurrent chromatography
  806. Effects of EGCG on the excessive activation of rat microglia cells induced by infrasound with 16 Hz, 155 dB
  807. Effects of white tea, EGCG and caffeine on PhIP-induced tumorigenesis and β-catenin expression
  808. Inhibition of Erlotinib-induced checkpoint but not apoptotic targets by EGCG: Implication for their anti-tumor synergism in squamous cell carcinoma of the head and …
  809. Effects of EGCG on UVB-induced p53 gene and protein expression in HaCaT keratinocytes
  810. Combinatorial effects of green tea polyphenol EGCG and NS-398, a COX-2 specific inhibitor on growth and apoptosis in androgen-dependent and-independent …
  811. Comparative Study Between Bevacizumab and 3-Epigallocatequin Gallate (EGCG) in the Regulation for VEGF and PEDF Expression in an Animal Model: Pilot Study
  812. Relationship between expression of Survivin and radio-sensitization effect of EGCG in xenotransplanted nasopharyngeal carcinoma.
  813. Inhibitory effect of oxidation products of EGCG on α-glucosidase
  814. Innate Immunity; Anti-cancer and anti-inflammatory effects of (-)-epigallocatechin-3-gallate (EGCG) by the modulation of the innate immunity
  815. Study on the Technology of Extraction and Purification of Tea Polyphenols and EGCG
  816. HPLC Determination of EGCG in Different Tea-leaves
  817. Oral administration of naturally occurring chitosan based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft …
  818. Abstract# 941: Synergistic growth inhibition of squamous cell carcinoma of the head and neck by Erlotinib and EGCG: the role of p53-dependent inhibition of nuclear …
  819. Abstract A95: Epigenetic changes in colon cancer cell lines treated with the green tea polyphenolic, EGCG
  820. (-)-Epigallocatechin-3-gallate (EGCG), green tea components, antagonize the anti-myeloma activity of proteasome inhibitor PS-341 by direct chemical interaction
  821. Two natural products, melatonin and EGCG from green tea, work synergistically to inhibit the HIV virus and restore the CD4 count in human volunteers
  822. Advances in research on Anticancer effect of (-)-Epigallocatechin Gallate (EGCG)[J]
  823. Effects of EGCG on the proliferation of human periodontal ligament cells
  824. Effect of EGCG in combination with gemcitabine on β-catenin expression in PANC-1 human pancreatic cancer cells
  825. Caveolae play a role in EGCG-mediated protection against linoleic acid-induced endothelial cell activation
  826. The Research Progress of Epigallocatechin Gallate (EGCG) on Weight Loss Mechanism
  827. Effects of EGCG on Trans-endothelial Migration of HepG2 Cells: Role of LOX-1
  828. THE EFFECT OF GREEN TEA EXTRACTION EGCG ON APOPTOSIS AND ANGIOGENESIS OF SMMC-7721 TRANSPLANTED TUMOR IN NUDE MICE
  829. Vitamin E and the green tea active agent EGCG suppress radiation-induced carcinogenesis by different molecular mechanisms
  830. Optimization of the extraction technology of EGCG from green tea
  831. Potential mechanisms for the cytotoxicity elicited by the combination of EGCG and raloxifene in MDA-MB-231 cells
  832. The green tea polyphenol, EGCG, inhibits HGF induced c-met signaling and scattering in the MCF10A breast epithelial cell line
  833. Molecular Changes and Effects of Epigallocatechin-3-gallate (EGCG) in Detachment-induced Cell Death
  834. Green Tea Extract (GTE) Catechin, Epigallocatechin Gallate (EGCG), Suppresses Ige Responses In Vitro
  835. Determination of EGCG in Green Tea and its Inhibitory Effect on Proliferation of Human Gastric Cancer Cell in vitro
  836. EGCG protects against oxLDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling
  837. Combined treatment of breast cancer cells with epigallocatechin gallate (EGCG) and Tamoxifen delays cell-growth in long-term culture: Implications for recurrent …
  838. Green tea catechin EGCG suppresses NUDT6 (nudix [nucleoside diphosphate linked moiety X]-type motif 6) expression in human colorectal cancer
  839. Modulation of expression of specific oncogenic and tumor suppressor microRNAs enhanced therapeutic efficacy of 4-HPR and EGCG in human malignant …
  840. Transport by OATP1B1 and OATP1B3 enhances cytotoxicity of EGCG and certain substituted quercetins
  841. EGCG and quercetin attenuate oxidized LDL-induced endothelial apoptosis via differential MAPK-responsive pathways
  842. 포스터 전시: 간; EGCG and Resveratrol Protect Human Hepatocyte Cells from Oxidative Stress
  843. Inhibition of influenza virus infection by epigallocatechin-3-O-gallate (EGCG) fatty acid monoesters
  844. Alteration of proteomic expression in apoptosis of human hepatocellular carcinoma cell line SMMC-7721 induced by EGCG
  845. Elimination of Caffeine from Catechins EGCG by Macroporous Adsorption Resins
  846. Reverse effect of EGCG, ECG on antibiotic resistance of heterogeneous vancomycin-resistant Staphylococcus
  847. VITAMIN E, LYCOPENE, AND EPIGALLOCATECHIN GALLATE (EGCG) SUPPLEMENTATION AND IMMUNE RESPONSE IN APO E KNOCK OUT (APOE-/-) MICE …
  848. Inhibition growth and survivin expression of nasopharyngeal carcinoma cell CNE-1 induced by EGCG
  849. Effect of EGCG on the Life of Drosophila melanogaster
  850. STUDY ON THE THERMAL STABILITY AND LIGHT PHOTOSTABILITY OF EGCG DERIVATIVES
  851. Kinetic Modeling of the Thermal Stability of EGCG in an Ultrasonic Filed
  852. Purification and Characterization of Recombinant EGCG-O-transferase from Tea Plant
  853. AD Model of α_3, α_7 nAChRs Deficits and the Protection of EGCG
  854. Neuroprotection of Green Tea Derived EGCG: Implications for HIV associated dementia
  855. Effects and Mechanisms of Epigallocatechin Gakkate (EGCG) on Bleomycin-induced Pulmonary Fibrosis in Mice
  856. The Safety of Epigallocatechin-3-Gallate (EGCG) as a Potential Chemopreventative and Chemotherapeutic Agents in Hepatocarcinogenesis
  857. Research Progress in the Effect of Antivirus of EGCG and its Derivatives
  858. Study on Extraction Technology of EGCG from the Green Tea
  859. New Preparation Technology and Structure Identification of EGCG Oxidation Products
  860. Interaction of Several EGCG-Metal Complexes with BSA
  861. P-0048: EGCG, a Green Tea Catechin, reduces pro-inflammatory cytokine production by CD14+ Macrophages, Lymphocytic CD45+ RO T cells, and mixed …
  862. Effect of EGCG on Renal Interstitial Fibrosis in Rats
  863. Chemotherapeutic sensitizing effect of peracetate EGCG on hepatocellular carcinoma cells
  864. Lamellar-bio nano-hybrid; The Study for Stability of Catechin (Green Tea: EGCG) Using 3-Dimensional Liposome
  865. Abstract# 33: In vitro and in vivo synergistic anti-tumor efficacy of two naturally available dietary polyphenols EGCG and luteolin
  866. Study on the antitumor effect of EGCG and ATRA on gastrointestinal stromal tumor cells and the potential therapeutic effect of PKC412 on leukemia cells harboring …
  867. Highly synergistic anti-tumor efficacy induced by the combination of two natural dietary agents, luteolin and EGCG: Role of p53 phosphorylation, stabilization and …
  868. The effect of adding β-cyclodextrins on the content of ester-catechin and EGCG in instant tea
  869. … (H2O2), rotenone and glutamate/buthionine sulfoximine (GB) are differentially protected by the flavonoids, epicatechin gallate (EG) epigallocatechin gallate (EGCG) …
  870. (−)-epigallocatechin-3-gallate (EGCG) 가 활성형 Akt 를 유도하는 경로
  871. Cross-talk between AMPK and GSK3beta or CSK in selenium-or EGCG-treated hepato-carcinoma cells
  872. Effects of Adding L-Ascorbic Acid on Contents of Easer-Catechin and EGCG of Instant Tea
  873. Dietary compounds EGCG and sulforaphane differentially reactivate ER-α in African American and Caucasian breast cancer cells.
  874. In vitro study on the metabolism of epigallocatechin gallate (EGCG) in mouse’s tissues
  875. The effect of different Formulation Parameters on The in vitro release of the (-)-EpiGallocatechin Gallate (EGCG) from concentrated w/o emulsions
  876. Effects of EGCG on the invasion, migration and cripto expression of human gastric cancer cell
  877. EGCG 처리된 구강편평세포암종 세포주에서 나타나는 HIF-1α 발현과 종양세포 표현형 변화-preliminary study
  878. The green tea polyphenol EGCG blocks H. pylori-induced scattering of gastric carcinoma cells, a process dependent on the activation of PI3K, p38 MAPK, and Rac1 …
  879. Study on the Separation Technique of EGCG and ECG with AB-8 Resin
  880. Influence of EGCG on Diabetic Nephropathy in Rats [J]
  881. Modeling the stability of green tea catechins EGCG and ECG during the biscuit making process
  882. Epigallocatechin-3-gallate (EGCG) 이 구강 편평세포암종 세포사를 유발하는 기전 연구
  883. Diet supplemented with UA or EGCG confer protection against DNA damage in colonocytes
  884. Development of EGCG probe molecules
  885. Directing glutamine and glucose metabolism with troglitazone and EGCG limits MCF-7 cell growth
  886. Effects of combined using of EGCG and taurine on apoptosis of lens epithelia cells in canine cataract models
  887. Inhibition effect of tea polyphenols and single L-EGCG on lipid peroxidation.
  888. 세포 부착 소실시 유도되는 세포사에 관련된 인자 및 Epigallocatechin-3-gallate (EGCG) 의 영향에 관한 연구
  889. COMPARATIVE EFFICACY OF EGCG VERSUS NANO EGCG ON EXTENUATING ATHEROSCLEROTIC EVENTS TRIGGERED BY HIGH CHOLESTEROL …
  890. EGCG Supplementation Improves Oxidant and Antioxidant Status in Kidney of Rats Exposed to Sevoflurane
  891. Effects of tea polyphenols EGCG on the mRNA expression in the osteogenic differentiation of human bone marrow stromal cells [J]
  892. The Relation Assessment Between 50 Hz Electric Field Exposure-Induced Protein Carbonyl Levels and The Protective Effect of Green Tea Catechin (EGCG)
  893. The Downregulation of Mast Cell Activation Through the Suppression of the High-Affinity IgE Receptor Expression by Green Tea Catechin EGCG
  894. EGCG İlavesi Sevofluran Uygulanan Ratların Böbreklerinde Oksidan ve Antioksidan Durumunu Düzenler
  895. The Hypocholesterolemic Effect of Green Tea EGCG Was Not Mediated Via the Stimulation of the Low-Density Lipoprotein Receptor Gene Expression in Cholesterol …
  896. Green tea catechin, EGCG, modulates mitochondrial dynamics in dopaminergic neurons of α-synuclein transgenic flies resulting in mobility improvement.
  897. Change of quality biochemical components in fresh leaves of tea in the process of inducing the increment of epigallocatechin gallate (EGCG)
  898. Analysis of differential gene expression profiles in human hepatocelluar cancer cell line SMMC-7721 by Epigallocatechin gallate (EGCG) applying Affymetrix Analysis …
  899. EFFECT OF GREEN TEA EPIGALLOCATECHIN-3-GALLATE (EGCG) ON PASSIVE AVOIDANCE LEARNING IN ADULT MALE WISTAR RATS
  900. The Effect of Epigallocatechin Gallate (EGCG) and Metal Ions Corroded from Dental Casting Alloys on Cell Cycle Progression and Apoptosis in Cells from Oral …
  901. NEW MODIFIED COTTON FIBER APPLY TO SEPARATE ECG AND EGCG FROM TEA EXTRACT
  902. Epigallocatechin-3-gallate (EGCG) ameliorates hyperglycemia-induced embryonic vasculopathy and malformation by inhibition of Foxo3a activation
  903. IMPACT OF EGCG ON MITIGATING HEPATIC STEATOSIS IN HIGH CHOLESTEROL DIET STRESSED YOUNG AND AGED RATS AN INSIGHT INTO …
  904. Oral composition containing EGCG and lycopene
  905. Oral composition containing EGCG and lycopene
  906. Study on High Levels of O-methylated EGCG in Hunan Tea Resources
  907. Study on the Impact of Caffeine and BSA on the Formation of TFDG by the Chemical Oxidation of EGCG and ECG
  908. Quantitative Analysis of Green Tea Components and In Vitro Testing for Interaction of EGCG with Selected Over-the-Counter Drugs
  909. Phase III management of papulopustular rosacea with 2% green tea extract (-) EGCG in a hydrophilic cream. A placebo-controlled, double-blind study Tanweer Syed …
  910. Analysis on the EGCG methylated derivatives produced from EGCG catalyzed by EGCG-O-Methyltransferase.
  911. Transglutaminase Inhibitor Comprising EGCG And A Method For Producing Thereof
  912. Study on the reaction condition of EGCG methylated derivatives produced from EGCG catalyzed by EGCG-O-Methyltransferase.
  913. The effects of (-)-epigallocatechin-3-O-gallate (EGCG), a green tea catechin, on blood cholesterol
  914. Epigallocatechin-3-gallate (EGCG), A Green Tea Polyphenol, Suppresses Hepatic Gluconeogenesis through…
  915. EGCG, a green tea polyphenol, improves endothelial
  916. Hybridization technique for tea plant lines with high EGCG content.
  917. Study on expression conditions of EGCG-O-Methyltransferase in recombinant Escherichia coli bacteria.
  918. EXPLORING THE BENEFICIAL ROLE OF EGCG IN ATTENUATING THE HEPATIC PRO ATHEROSCLEROTIC EVENTS IN HYPERCHOLESTEROLEMIA …
  919. Effects of EGCG on in vitro cultured nuded oocytes of mouse.
  920. Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate (EGCG) on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts
  921. Effects of EGCG from green tea on IL-1β-induced expression of MMP-1 and MMP-13, and production of PGE2 and NO on human IVD cells in vitro
  922. Separation and purification of EGCG in catechins by HP-20 macroporous resin.
  923. The Green Tea Polyphenol, EGCG, Potentiates the Anti-Proliferative Activity of c-Met and EGFR Inhibitors in Non-Small Cell Lung Cancer Cells
  924. Growth inhibitory effects in vivo of epigallocatechin-3-gallate (EGCG) on avian malarial parasite.
  925. EGCG and its role in prostate cancer angiogenesis
  926. Effect of Dietary EGCG on Normal and Vitamin E and Selenium Deficient Rats
  927. Effects of caffeic acid, chlorogenic acid, and EGCG on the methylation status of p16 gene in T-47D breast cancer cells
  928. Separation and purification of epigallocatechin gallate (EGCG) by macroporus resin.
  929. Combination of EGCG or methylated EGCG and a pde inhibitor
  930. The Effect of Epigallocatechin gallate (EGCG) on Mycobacterium tuberculosis and Mycobacterium smegmatis
  931. EGCG and voluntary exercise: an examination of treatment effects using the TgCRND8 mouse model of Alzheimer’s disease
  932. Development of a topical epigallocatechin gallate (EGCG) formulation
  933. Anti-obesity effects of green tea EGCG, orange peel extract, black tea extract and caffeine in mice fed on a high-fat diet
  934. Anti-infective properties of Epigallocatechin-3-gallate (EGCG), a component of
  935. Green Tea Compound Reduces Lipid Accumulation in Cells♦: Epigallocatechin Gallate (EGCG) Stimulates Autophagy in Vascular Endothelial Cells. A Potential Role …
  936. EPIGALLOCATECHIN-3-GALLATE (EGCG), A GREEN TEA-DERIVED POLYPHENOL, ATTENUATES CARDIAC INJURY IN A RAT MODEL OF MYOCARDIAL …
  937. EPIGALLOCATECHIN-3-GALLATE (EGCG) INHIBITS IL-1β SIGNAL TRANSDUCTION: 38
  938. Thermal induced coupling of cell adhesion/deadhesion and migration under HBV replication and EGCG treatment
  939. … 4-pentahydroxy-flavan), epigallocatechin (EGC; 5-hydroxy-epicatechin), epicatechin-3-O-gallate (ECG),()-epigallocatechin-3-O-gallate (EGCG) and ()-gallocatechin-3 …
  940. Green tea epigallocatechin-3-gallate (EGCG) inhibits cytokine-induced nitric oxide and secretory phospholipase A2-IIA in glial cells
  941. Study on the analytical method of EGCG 3 ″Me by HPLC in tea.
  942. EGCG and Resveratrol Inhibit Phorbol Ester-Induced COX-2 Expression in Mouse Skin by Downregulating ERK and p38 MAP Kinases
  943. Anticancer Effect and Gene Expression Regulation of Major Constituent of Green Tea, EGCG in Gynecologic Cancers
  944. Suppression of Met signaling by the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG)
  945. Investigation of the structure -activity relationship (SAR)of natural products ((−)-EGCG from green tea and YCK from Murraya paniculata)
  946. A study of implantable EGCG formulated collagen bioprosthetic material
  947. A transgenic mouse line overexpressing the anticancer green tea target, tNOX, responds to EGCG
  948. Role of Green Tea Polyphenol (EGCG) in the Pathogenesis of Mycobacterium tuberculosis
  949. Physiological responses of LNCaP prostate cancer cells to epigallocatechin-3-gallate (EGCG), thymoquinone (TQ), and tannic acid (TA) alone and in …
  950. Effects of green tea extract and epigallocatechin-3-gallate (EGCG) on xenobiotic transporter and metabolizing enzyme gene expression profiles in CACO-2 cells
  951. Inhibition of lung tumorigenesis and cancer cell growth by EGCG and other chemopreventive agents
  952. Epigallocatechin-3-Gallete (EGCG) Modulates Neutrophil Apoptosis and the Production of Reactive Oxygen Species
  953. EGCG 抑制造骨細胞 MCP-1 基因表現的訊息傳導的機制及對根尖病變進展的影響
  954. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance
  955. The green tea molecule EGCG inhibits Zika virus entry
  956. NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells
  957. Quercetin and EGCG exhibit chemopreventive effects in cholangiocarcinoma cells via suppression of JAK/STAT signaling pathway
  958. Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer’s disease mouse model
  959. EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells
  960. Epigallocatechin-3-gallate (EGCG) as a pro-osteogenic agent to enhance osteogenic differentiation of mesenchymal stem cells from human bone marrow: an in vitro …
  961. Autophagy inhibition contributes to the synergistic interaction between EGCG and doxorubicin to kill the hepatoma Hep3B cells
  962. Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
  963. Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-β aggregation and cytotoxicity
  964. Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer …
  965. Facile EGCG assisted green synthesis of raspberry shaped CdO nanoparticles
  966. EGCG attenuates autoimmune arthritis by inhibition of STAT3 and HIF-1α with Th17/Treg control
  967. EGCG decreases the expression of HIF-1α and VEGF and cell growth in MCF-7 breast cancer cells.
  968. Effects of oolong tea polyphenols, EGCG, and EGCG3 ″Me on pancreatic α-amylase activity in vitro
  969. EGCG enhances the efficacy of cisplatin by downregulating hsa-miR-98-5p in NSCLC A549 cells
  970. EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition
  971. Improving the effectiveness of (−)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and …
  972. Impact of chitosan–EGCG conjugates on physicochemical stability of β-carotene emulsion
  973. Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1
  974. Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation
  975. EGCG enhances cisplatin sensitivity by regulating expression of the copper and cisplatin influx transporter CTR1 in ovary cancer
  976. In vitro activity of curcumin in combination with epigallocatechin gallate (EGCG) versus multidrug-resistant Acinetobacter baumannii
  977. Optimization on condition of epigallocatechin-3-gallate (EGCG) nanoliposomes by response surface methodology and cellular uptake studies in Caco-2 cells
  978. Green tea polyphenol EGCG suppresses W nt/β‐catenin signaling by promoting GSK‐3β‐and PP2A‐independent β‐catenin phosphorylation/degradation
  979. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer
  980. Evaluation of structural and functional properties of protein–EGCG complexes and their ability of stabilizing a model β-carotene emulsion
  981. A prospective phase II trial of EGCG in treatment of acute radiation-induced esophagitis for stage III lung cancer
  982. Gene regulation mediated by microRNAs in response to green tea polyphenol EGCG in mouse lung cancer
  983. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review
  984. Green tea polyphenol EGCG reverse cisplatin resistance of A549/DDP cell line through candidate genes demethylation
  985. EGCG assisted green synthesis of ZnO nanopowders: Photodegradative, antimicrobial and antioxidant activities
  986. The Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) Attenuates Skeletal Muscle Atrophy in a Rat Model of Sarcopenia.
  987. Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies
  988. Protective effects of epigallocatechin gallate (EGCG) on streptozotocin-induced diabetic nephropathy in mice
  989. Antigenotoxic effects of (–)-epigallocatechin-3-gallate (EGCG), quercetin, and rutin on chromium trioxide-induced micronuclei in the polychromatic erythrocytes of …
  990. EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in …
  991. Assessment of extraction parameters on antioxidant capacity, polyphenol content, epigallocatechin gallate (EGCG), epicatechin gallate (ECG) and iriflophenone 3-C-β …
  992. Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver …
  993. The green tea polyphenol EGCG inhibits E. coli biofilm formation by impairing amyloid curli fibre assembly and downregulating the biofilm regulator CsgD via the σE …
  994. Targeting cancer with nano-bullets: curcumin, EGCG, resveratrol and quercetin on flying carpets
  995. Fabrication of self-assembled (−)-epigallocatechin gallate (EGCG) ovalbumin–dextran conjugate nanoparticles and their transport across monolayers of human …
  996. EGCG-mediated autophagy flux has a neuroprotection effect via a class III histone deacetylase in primary neuron cells
  997. Epigallocatechin-3-gallate (EGCG) attenuates concanavalin A-induced hepatic injury in mice
  998. Green tea compound epigallo-catechin-3-gallate (EGCG) increases neuronal survival in adult hippocampal neurogenesis in vivo and in vitro
  999. Epigallocatechin gallate (EGCG) attenuates infrasound-induced neuronal impairment by inhibiting microglia-mediated inflammation
  1000. Epigallocatechin gallate (EGCG) suppresses lipopolysaccharide‐induced inflammatory bone resorption, and protects against alveolar bone loss in mice
  1001. Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCG): review of recent advances from …
  1002. EGCG inhibits Cd2+-induced apoptosis through scavenging ROS rather than chelating Cd2+ in HL-7702 cells
  1003. Physicochemical properties of β-carotene bilayer emulsions coated by milk proteins and chitosan–EGCG conjugates
  1004. Protective effect of epigallocatechin-3-gallate (EGCG) via Nrf2 pathway against oxalate-induced epithelial mesenchymal transition (EMT) of renal tubular cells
  1005. EGCG/gelatin-doxorubicin gold nanoparticles enhance therapeutic efficacy of doxorubicin for prostate cancer treatment
  1006. Preparation and functional evaluation of chitosan‐EGCG conjugates
  1007. EGCG prevents PCB-126-induced endothelial cell inflammation via epigenetic modifications of NF-κB target genes in human endothelial cells
  1008. Implication of Akt, ERK1/2 and alternative p38MAPK signalling pathways in human colon cancer cell apoptosis induced by green tea EGCG
  1009. Stability and bioaccessibility of EGCG within edible micro-hydrogels. Chitosan vs. gelatin, a comparative study
  1010. Lipase-catalyzed synthesis of acetylated EGCG and antioxidant properties of the acetylated derivatives
  1011. Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases
  1012. Synthesis of gelatin-γ-polyglutamic acid-based hydrogel for the in vitro controlled release of epigallocatechin gallate (EGCG) from Camellia sinensis
  1013. Mechanism for the antibacterial action of epigallocatechin gallate (EGCG) on Bacillus subtilis
  1014. Epigallocatechin-3-gallate (EGCG) protects skin cells from ionizing radiation via heme oxygenase-1 (HO-1) overexpression
  1015. EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism
  1016. EGCG inhibits the growth and tumorigenicity of nasopharyngeal tumor-initiating cells through attenuation of STAT3 activation
  1017. Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy
  1018. EGCG attenuates pro-inflammatory cytokines and chemokines production in LPS-stimulated L02 hepatocyte
  1019. EGCG attenuates uric acid-induced inflammatory and oxidative stress responses by medicating the NOTCH pathway
  1020. Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin …
  1021. The activity of catechol-O-methyltransferase (COMT) is not impaired by high doses of epigallocatechin-3-gallate (EGCG) in vivo
  1022. Fabrication of coated bovine serum albumin (BSA)–epigallocatechin gallate (EGCG) nanoparticles and their transport across monolayers of human intestinal epithelial …
  1023. Potential role of (-)-epigallocatechin-3-gallate (EGCG) in the secondary prevention of Alzheimer disease
  1024. Wnt/β-catenin pathway mediates (−)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells
  1025. Therapeutic effects of EGCG: a patent review
  1026. Epigallocatechin-3-gallate (EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity
  1027. EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9
  1028. The effect of epigallocatechin-3-gallate (EGCG) on human alveolar bone cells both in vitro and in vivo
  1029. Novel EGCG assisted ultrasound synthesis of self-assembled Ca2SiO4: Eu3+ hierarchical superstructures: Photometric characteristics and LED applications
  1030. Exploring the influence of EGCG on the β-sheet-rich oligomers of human islet amyloid polypeptide (hIAPP1–37) and identifying its possible binding sites from …
  1031. … of laminae I–III exhibit oxidative stress damage during diabetic neuropathy which is prevented by early antioxidant treatment with epigallocatechin-gallate (EGCG)
  1032. EGCG ameliorates high-fat–and high-fructose–induced cognitive defects by regulating the IRS/AKT and ERK/CREB/BDNF signaling pathways in the CNS
  1033. Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model
  1034. NMR and molecular fluorescence spectroscopic study of the structure and thermodynamic parameters of EGCG/β-cyclodextrin inclusion complexes with potential …
  1035. Epigallocatechin gallate (EGCG) inhibits alpha-synuclein aggregation: a potential agent for Parkinson’s disease
  1036. Molecular docking and molecular dynamics studies reveal structural basis of inhibition and selectivity of inhibitors EGCG and OSU-03012 toward glucose regulated …
  1037. The therapeutic effects of EGCG on vitiligo
  1038. Immunomodulatory effects of EGCG fraction of green tea extract in innate and adaptive immunity via T regulatory cells in murine model
  1039. (−)-Epigallocatechin-3-gallate (EGCG) modulates neurological function when intravenously infused in acute and, chronically injured spinal cord of adult rats
  1040. Preparation, characterization, and in vitro antitumor activity of folate conjugated chitosan coated EGCG nanoparticles
  1041. Epigallocatechin-3-gallate (EGCG) attenuates traumatic brain injury by inhibition of edema formation and oxidative stress
  1042. Cancer prevention with green tea and its principal constituent, EGCG: From early investigations to current focus on human cancer stem cells
  1043. Epigallocatechin gallate (EGCG) inhibits adhesion and migration of neural progenitor cells in vitro
  1044. Evaluation of epigallocatechin-3-gallate (EGCG) cross-linked collagen membranes and concerns on osteoblasts
  1045. Tea polyphenols EGCG and TF restrict tongue and liver carcinogenesis simultaneously induced by N-nitrosodiethylamine in mice
  1046. … -3-O-gallate modulates global microRNA expression in interleukin-1β-stimulated human osteoarthritis chondrocytes: potential role of EGCG on negative co-regulation …
  1047. EGCG attenuates atherosclerosis through the Jagged-1/Notch pathway
  1048. Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical …
  1049. Antimicrobial potential of epigallocatechin-3-gallate (EGCG): a green tea polyphenol
  1050. Improving the anticancer efficacy of laminin receptor-specific therapeutic ruthenium nanoparticles (RuBB-loaded EGCG-RuNPs) via ROS-dependent apoptosis in …
  1051. Hyaluronic acid/PLGA core/shell fiber matrices loaded with EGCG beneficial to diabetic wound healing
  1052. EGCG protects against 6-OHDA-induced neurotoxicity in a cell culture model
  1053. Novel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in mice
  1054. The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach
  1055. Application of PEG and EGCG modified collagen-base membrane to promote osteoblasts proliferation
  1056. Epigallocatechin Gallate (EGCG) Prevents H2O2-Induced Oxidative Stress in Primary Rat Retinal Pigment Epithelial Cells
  1057. New epigallocatechin gallate (EGCG) nanocomplexes co-assembled with 3-mercapto-1-hexanol and β-lactoglobulin for improvement of antitumor activity
  1058. EGCG ameliorates diet-induced metabolic syndrome associating with the circadian clock
  1059. Inhibition of green tea polyphenol EGCG ((−)-epigallocatechin-3-gallate) on the proliferation of gastric cancer cells by suppressing canonical Wnt/β-catenin signalling …
  1060. Compounds derived from epigallocatechin-3-gallate (EGCG) as a novel approach to the prevention of viral infections
  1061. Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice
  1062. Changes in the physiology and gene expression of Microcystis aeruginosa under EGCG stress
  1063. Epigallocatechin gallate (EGCG) decorating soybean seed ferritin as a rutin nanocarrier with prolonged release property in the gastrointestinal tract
  1064. The green tea polyphenol EGCG alleviates maternal diabetes–induced neural tube defects by inhibiting DNA hypermethylation
  1065. In vitro evaluation of the antiviral activity of the synthetic epigallocatechin gallate analog-epigallocatechin gallate (EGCG) palmitate against porcine reproductive and …
  1066. EGCG assisted Y2O3: Eu3+ nanopowders with 3D micro-architecture assemblies useful for latent finger print recognition and anti-counterfeiting applications
  1067. A prodrug of green tea polyphenol (–)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer
  1068. EGCG protects against homocysteine-induced human umbilical vein endothelial cells apoptosis by modulating mitochondrial-dependent apoptotic signaling and PI3K …
  1069. Evaluation of nanohydroxyapaptite (nano-HA) coated epigallocatechin-3-gallate (EGCG) cross-linked collagen membranes
  1070. Epigallocatechin-3-gallate (EGCG) activates AMPK through the inhibition of glutamate dehydrogenase in muscle and pancreatic ß-cells: A potential beneficial effect in …
  1071. A-type dimeric epigallocatechin-3-gallate (EGCG) is a more potent inhibitor against the formation of insulin amyloid fibril than EGCG monomer
  1072. Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles
  1073. Epigallocatechin gallate (EGCG) suppresses lipopolysaccharide-induced Toll-like receptor 4 (TLR4) activity via 67 kDa laminin receptor (67LR) in 3T3-L1 adipocytes
  1074. Separation and purification of epigallocatechin-3-gallate (EGCG) from green tea using combined macroporous resin and polyamide column chromatography
  1075. EGCG ameliorates the hypoxia-induced apoptosis and osteogenic differentiation reduction of mesenchymal stem cells via upregulating miR-210
  1076. (-)-Epigallocatechin-3-gallate (EGCG) attenuates arsenic-induced cardiotoxicity in rats
  1077. The effects of Erh BMP‐2‐/EGCG‐coated BCP bone substitute on dehiscence around dental implants in dogs
  1078. Effects of EGCG content in green tea extract on pharmacokinetics, oxidative status and expression of inflammatory and apoptotic genes in the rat ocular tissues
  1079. EGCG prevents high fat diet-induced changes in gut microbiota, decreases of DNA strand breaks, and changes in expression and DNA methylation of Dnmt1 and …
  1080. Epigallocatechin gallate (EGCG) induced chemical conversion coatings for corrosion protection of biomedical MgZnMn alloys
  1081. EGCG, a green tea catechin, attenuates the progression of heart failure induced by the heart/muscle-specific deletion of MnSOD in mice
  1082. Analysis of the effect of the active compound of green tea (EGCG) on the proliferation of peripheral blood mononuclear cells
  1083. “Benifuuki” green tea, containing O-methylated EGCG, reduces serum low-density lipoprotein cholesterol and lectin-like oxidized low-density lipoprotein …
  1084. P38 MAPK/miR‐1 are involved in the protective effect of EGCG in high glucose‐induced Cx43 downregulation in neonatal rat cardiomyocytes
  1085. Laminin receptor-avid nanotherapeutic EGCG-AuNPs as a potential alternative therapeutic approach to prevent restenosis
  1086. Inhibitory effects of green tea polyphenol epigallocatechin gallate (EGCG) on exopolysaccharide production by Streptococcus mutans under microfluidic conditions
  1087. Delayed treatment with green tea polyphenol EGCG promotes neurogenesis after ischemic stroke in adult mice
  1088. The green tea polyphenol EGCG potentiates the antiproliferative activity of sunitinib in human cancer cells
  1089. Phytoferritin association induced by EGCG inhibits protein degradation by proteases
  1090. Green tea polyphenol EGCG causes anti-cancerous epigenetic modulations in acute promyelocytic leukemia cells
  1091. EGCG induces lung cancer A549 cell apoptosis by regulating Ku70 acetylation
  1092. A-type ECG and EGCG dimers disturb the structure of 3T3-L1 cell membrane and strongly inhibit its differentiation by targeting peroxisome proliferator-activated …
  1093. Cancer preventive and therapeutic effects of EGCG, the major polyphenol in green tea
  1094. Anti-cancer effect of (-)-epigallocatechin-3-gallate (EGCG) in head and neck cancer through repression of transactivation and enhanced degradation of β-catenin
  1095. Certain (−)-epigallocatechin-3-gallate (EGCG) auto-oxidation products (EAOPs) retain the cytotoxic activities of EGCG
  1096. Combination of erlotinib and EGCG induces apoptosis of head and neck cancers through posttranscriptional regulation of Bim and Bcl-2
  1097. Reduction in promotor methylation utilizing EGCG (epigallocatechin-3-gallate) restores RXRα expression in human colon cancer cells
  1098. (−)-Epigallocatechin-3-gallate (EGCG) inhibits fibrillation, disaggregates amyloid fibrils of α-synuclein, and protects PC12 cells against α-synuclein-induced …
  1099. Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes
  1100. Antiglycation activity of lipophilized epigallocatechin gallate (EGCG) derivatives
  1101. Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome
  1102. Anti-obesity effect of EGCG and glucosamine-6-phosphate through decreased expression of genes related to adipogenesis and cell cycle arrest in 3T3-L1 …
  1103. Combination of siRNA-directed gene silencing with epigallocatechin-3-gallate (EGCG) reverses drug resistance in human breast cancer cells
  1104. Metformin sensitizes non-small cell lung cancer cells to an epigallocatechin-3-gallate (EGCG) treatment by suppressing the Nrf2/HO-1 signaling pathway
  1105. Mechanism of EGCG promoting apoptosis of MCF-7 cell line in human breast cancer
  1106. PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma
  1107. Physiological effects of epigallocatechin-3-gallate (EGCG) on energy expenditure for prospective fat oxidation in humans: A systematic review and meta-analysis
  1108. Reduction in autophagy by (-)-epigallocatechin-3-gallate (EGCG): A potential mechanism of prevention of mitochondrial dysfunction after subarachnoid hemorrhage
  1109. Preparation and characterization of (−)-Epigallocatechin-3-gallate (EGCG)-loaded nanoparticles and their inhibitory effects on Human breast cancer MCF-7 …
  1110. EGCG inhibited bladder cancer T24 and 5637 cell proliferation and migration via PI3K/AKT pathway
  1111. NEAT1 acts as an inducer of cancer stem cell‐like phenotypes in NSCLC by inhibiting EGCG‐upregulated CTR1
  1112. A 3-day EGCG-supplementation reduces interstitial lactate concentration in skeletal muscle of overweight subjects
  1113. EGCG-mediated Protection of the Membrane Disruption and Cytotoxicity Caused by the ‘Active Oligomer’of α-Synuclein
  1114. … hepatic steatosis in L02 cells by targeting miR-122 and miR-33b and its effects closely associated with the A type ECG dimer and EGCG dimer structural units
  1115. Antioxidant and Antimicrobial Activities of (‐)‐Epigallocatechin‐3‐gallate (EGCG) and its Potential to Preserve the Quality and Safety of Foods
  1116. EGCG reverses human neutrophil elastase-induced migration in A549 cells by directly binding to HNE and by regulating α1-AT
  1117. Epigallocatechin‐3‐Gallate (EGCG) Reduces Rotenone Effect on Stallion Sperm–Zona Pellucida Heterologous Binding
  1118. Green tea polyphenol EGCG alleviates metabolic abnormality and fatty liver by decreasing bile acid and lipid absorption in mice
  1119. EGCG inhibits the oligomerization of amyloid beta (16-22) hexamer: theoretical studies
  1120. Differential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non‐small cells lung cancer to chemotherapy
  1121. Schedule-dependent effect of Epigallocatechin-3-Gallate (EGCG) with paclitaxel on H460 cells
  1122. (−)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice
  1123. EGCG decreases binding of calcium oxalate monohydrate crystals onto renal tubular cells via decreased surface expression of alpha-enolase
  1124. EGCG blocked phenylephrin-induced hypertrophy in H9C2 cardiomyocytes, by activating AMPK-dependent pathway
  1125. Long-Term Effects of (–)-Epigallocatechin Gallate (EGCG) on Pristane-Induced Arthritis (PIA) in Female Dark Agouti Rats
  1126. EGCG, a tea polyphenol, as a potential mitigator of hematopoietic radiation injury in mice
  1127. Epigallocatechin-3-gallate (EGCG) suppresses the trafficking of lymphocytes to epidermal melanocytes via inhibition of JAK2: Its implication for vitiligo treatment
  1128. Nephro-toxic effects of intraperitoneally injected EGCG in diabetic mice: involvement of oxidative stress, inflammation and apoptosis
  1129. PPARα activation sensitizes cancer cells to Epigallocatechin-3-Gallate (EGCG) treatment via suppressing heme oxygenase-1
  1130. Synthesis and biological testing of novel glucosylated epigallocatechin gallate (EGCG) derivatives
  1131. Expression profiling of genes modulated by estrogen, EGCG or both in MCF-7 breast cancer cells
  1132. Reversal of 5-fluorouracil resistance by EGCG is mediate by inactivation of TFAP2A/VEGF signaling pathway and down-regulation of MDR-1 and P-gp …
  1133. Effect of (−)-epigallocatechin gallate (EGCG) extracted from green tea in reducing the formation of acrylamide during the bread baking process
  1134. EGCG stabilizes growth cone filopodia and impairs retinal ganglion cell axon guidance
  1135. EGCG regulates the cross-talk between JWA and topoisomerase IIα in non-small-cell lung cancer (NSCLC) cells
  1136. A new molecular mechanism underlying the EGCG-mediated autophagic modulation of AFP in HepG2 cells
  1137. The fungal laccase‐catalyzed oxidation of EGCG and the characterization of its products
  1138. The antioxidant effect of Green Tea Mega EGCG against electromagnetic radiation-induced oxidative stress in the hippocampus and striatum of rats
  1139. Skin delivery of EGCG and silibinin: potential of peptide dendrimers for enhanced skin permeation and deposition
  1140. Suppressive effects of EGCG on cervical cancer
  1141. Oligomer formation of a tea polyphenol, EGCG, on its sensing molecule 67 kDa laminin receptor
  1142. The involvement of Nrf2 in the protective effects of (-)-Epigallocatechin-3-gallate (EGCG) on NaAsO2-induced hepatotoxicity
  1143. Epigallocatechin gallate-β-lactoglobulin nanoparticles improve the antitumor activity of EGCG for inducing cancer cell apoptosis
  1144. Hydrogen sulphide donors selectively potentiate a green tea polyphenol EGCG-induced apoptosis of multiple myeloma cells
  1145. Attenuated migration by green tea extract (−)-epigallocatechin gallate (EGCG): involvement of 67 kDa laminin receptor internalization in macrophagic cells
  1146. Green tea catechin, EGCG, suppresses PCB 102-induced proliferation in estrogen-sensitive breast cancer cells
  1147. EGCG mediated downregulation of NF-AT and macrophage infiltration in experimental hepatic steatosis
  1148. Effect of Epigallocatechin-3-gallate (EGCG) on cell proliferation inhibition and apoptosis induction in lymphoblastic leukemia cell line
  1149. Epigallocatechin-3-gallate (EGCG) promotes autophagy-dependent survival via influencing the balance of mTOR-AMPK pathways upon endoplasmic reticulum stress
  1150. Radiolabeling of EGCG with 125I and its biodistribution in mice
  1151. Fabrication and optimization of EGCG‐loaded nanoparticles by high pressure homogenization
  1152. SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition
  1153. Impact of EGCG supplementation on the progression of diabetic nephropathy in rats: an insight into fibrosis and apoptosis
  1154. Anti-fatigue effect of green tea polyphenols (-)-Epigallocatechin-3-Gallate (EGCG)
  1155. The up-regulation of Myb may help mediate EGCG inhibition effect on mouse lung adenocarcinoma
  1156. Copolymeric micelles for delivery of EGCG and cyclopamine to pancreatic cancer cells
  1157. Molecular targets of epigallocatechin—Gallate (EGCG): A special focus on signal transduction and cancer
  1158. Modulation of hexavalent chromium-induced genotoxic damage in peripheral blood of mice by epigallocatechin-3-gallate (EGCG) and its relationship to the apoptotic …
  1159. NRF2 plays a critical role in both self and EGCG protection against diabetic testicular damage
  1160. EGCG suppresses ERK5 activation to reverse tobacco smoke-triggered gastric epithelial-mesenchymal transition in BALB/c mice
  1161. EGCG in green tea induces aggregation of HMGB1 protein through large conformational changes with polarized charge redistribution
  1162. Evaluation of non-covalent ternary aggregates of lactoferrin, high methylated pectin, EGCG in stabilizing β-carotene emulsions
  1163. Anti-cancer effect of EGCG and its mechanisms
  1164. Green tea component EGCG, insulin and IGF-1 promote nuclear efflux of atrophy-associated transcription factor Foxo1 in skeletal muscle fibers
  1165. Epistructured catechins, EGCG and EC facilitate apoptosis induction through targeting de novo lipogenesis pathway in HepG2 cells
  1166. Effect of EGCG On Fe (III)‐induced conformational transition of silk fibroin, a model of protein related to neurodegenerative diseases
  1167. Virucidal capacity of novel ProtecTeaV sanitizer formulations containing lipophilic epigallocatechin-3-gallate (EGCG)
  1168. Prostate-specific membrane antigen (PSMA)-targeting nanobioconjugate-encapsulated green tea polyphenol EGCG for prostate cancer prevention and therapy
  1169. FBS or BSA inhibits EGCG induced cell death through covalent binding and the reduction of intracellular ROS production
  1170. In vitro and in silico studies of the molecular interactions of epigallocatechin-3-o-gallate (EGCG) with proteins that explain the health benefits of green tea
  1171. Neuroprotective effects of (−)-epigallocatechin-3-gallate (EGCG) against peripheral nerve transection-induced apoptosis
  1172. EGCG protective mitochondrial dysfunction after subarachnoid haemorrhage via inhibition p38 α pathway
  1173. GPCR6A is a molecular target for the natural products gallate and EGCG in green tea
  1174. Differences in the effects of EGCG on chromosomal stability and cell growth between normal and colon cancer cells
  1175. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG)
  1176. Tea-induced improvement of endothelial function in humans: No role for epigallocatechin gallate (EGCG)
  1177. Using different natural origin carriers for development of epigallocatechin gallate (EGCG) solid formulations with improved antioxidant activity by PGSS-drying
  1178. Comparison of disaggregative effect of A-type EGCG dimer and EGCG monomer on the preformed bovine insulin amyloid fibrils
  1179. EGCG inhibited lipofuscin formation based on intercepting amyloidogenic β-sheet-rich structure conversion
  1180. An in vitro evaluation of epigallocatechin gallate (EGCG) as a biocompatible inhibitor of ricin toxin
  1181. (−)-Epigallocatechin-3-gallate (EGCG) inhibits starch digestion and improves glucose homeostasis through direct or indirect activation of PXR/CAR-mediated phase II …
  1182. Computational and biochemical discovery of RSK2 as a novel target for epigallocatechin gallate (EGCG)
  1183. Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models
  1184. Whole transcriptome analysis of three leaf stages in two cultivars and one of their F1 hybrid of Camellia sinensis L. with differing EGCG content
  1185. The anti-hyperuricemic effect of epigallocatechin-3-gallate (EGCG) on hyperuricemic mice
  1186. Shelf-stable, clear liquid nutritional compositions comprising epigallocatechin gallate (EGCG) and methods for preparing the same
  1187. The Effects of Metformin and EGCG On PANC-1 Cell Survival.
  1188. Effects of green tea and its epigallocatechin (EGCG) content on body weight and fat mass in humans: a systematic review
  1189. EGCG reduces obesity and white adipose tissue gaining partly through AMPK activation in mice
  1190. Macrophage phenotype in the epigallocatechin‐3‐gallate (EGCG)‐modified collagen determines foreign body reaction
  1191. Quantitative proteomic analysis reveals the role of tea polyphenol EGCG in egg whites in response to vanadium stress
  1192. EGCG evokes Nrf2 nuclear translocation and dampens PTP1B expression to ameliorate metabolic misalignment under insulin resistance condition
  1193. In vitro Biological Effects of Sulforaphane (SFN), Epigallocatechin-3-gallate (EGCG), and Curcumin on Breast Cancer Cells: A Systematic Review of the Literature
  1194. Formulation and characterization of EGCG for the treatment of superficial bladder cancer
  1195. Green tea EGCG, T-cell function, and T-cell-mediated autoimmune encephalomyelitis
  1196. Epigallocatechin gallate (EGCG) esters with different chain lengths fatty acids and their antioxidant activity in food and biological systems
  1197. Suitability of EGCG as a means of stabilizing a porcine osteochondral xenograft
  1198. Green tea polyphenol EGCG upregulates Tollip expression by suppressing Elf-1 expression
  1199. Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice
  1200. EGCG nanoparticles attenuate aluminum chloride induced neurobehavioral deficits, beta amyloid and tau pathology in a rat model of Alzheimer’s disease
  1201. Central composite design for optimizing extraction of EGCG from green tea leaf (Camellia sinensis L.)
  1202. Impact and significance of EGCG on Smad, ERK, and β-catenin pathways in transdifferentiation of renal tubular epithelial cells
  1203. Inhibitory effect of the green tea molecule EGCG against dengue virus infection
  1204. Evaluation of plasma antioxidant activity in rats given excess EGCG with reference to endogenous antioxidants concentrations and assay methods
  1205. Modified Green Tea Polyphenols, EGCG-S and LTP, Inhibit Endospore in Three Bacillus spp.
  1206. Epigallocatechin gallate (EGCG) suppresses epithelial-Mesenchymal transition (EMT) and invasion in anaplastic thyroid carcinoma cells through blocking of TGF-β1 …
  1207. Preparation and physicochemical characterization of poly (D, L-lactide-co-glycolide) nanoparticles for controlled release of EGCG
  1208. Effects of O‐methylated (−)‐epigallocatechin gallate (EGCG) on LPS‐induced osteoclastogenesis, bone resorption, and alveolar bone loss in mice
  1209. Synergistic effects of combination treatment using EGCG and suramin against the chikungunya virus
  1210. Advancing insights on the anti-obesity biochemical mechanism of (−)-epigallocatechin gallate (EGCG) by inhibiting α-amylase activity
  1211. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin
  1212. Metal chelator EGCG attenuates Fe (III)‐induced conformational transition of α‐synuclein and protects AS‐PC 12 cells against Fe (III)‐induced death
  1213. Better management of alcohol liver disease using a ‘Microstructured Synbox’System comprising L. plantarum and EGCG
  1214. Achievable central nervous system concentrations of the green tea catechin EGCG induce stress in glioblastoma cells in vitro
  1215. Neuroprotective effect of epigallocatechin-3-gallate (EGCG) on radiation-induced damage and apoptosis in the rat hippocampus
  1216. Ferritin glycosylated by chitosan as a novel EGCG nano-carrier: Structure, stability, and absorption analysis
  1217. Binding affinity analysis and ADMET prediction of epigallocatechine gallate (EGCG) derivatives for AP-1 protein: a drug target for liver cancer
  1218. Application of non-invasive low strength pulsed electric field to EGCG treatment synergistically enhanced the inhibition effect on PANC-1 cells
  1219. Targeting the DNA repair endonuclease ERCC1-XPF with green tea polyphenol epigallocatechin-3-gallate (EGCG) and its prodrug to enhance cisplatin efficacy in …
  1220. Correction: Epigallocatechin-3-Gallate (EGCG), a Green Tea Polyphenol, Stimulates Hepatic Autophagy and Lipid Clearance
  1221. Epigallocatechin-3-gallate (EGCG): mechanisms and the combined applications
  1222. Effect of extraction conditions of green tea on Antioxidant activity and EGCG content: optimization using response surface methodology
  1223. Urea-Driven Epigallocatechin Gallate (EGCG) Permeation into the Ferritin Cage, an Innovative Method for Fabrication of Protein–Polyphenol Co-assemblies
  1224. Neurorescue effect of EGCG in an animal model of Parkinson’s disease
  1225. MoO3 nanostructures from EGCG assisted sonochemical route: evaluation of its application towards forensic and photocatalysis
  1226. Binding interaction between (−)-epigallocatechin-3-gallate (EGCG) of green tea and pepsin
  1227. Eco-friendly synthesis of lipophilic EGCG derivatives and antitumor and antioxidant evaluation
  1228. EGCG prevents tryptophan oxidation of cataractous ocular lens human γ-crystallin in presence of H2O2
  1229. Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25
  1230. Correction: EGCG enhances cisplatin sensitivity by regulating expression of the copper and cisplatin influx transporter CTR1 in ovary cancer
  1231. Possible hepatocellular toxicity of EGCG under the influence of an inflammagen
  1232. The effects of EGCG on the mechanical, bioactivities, cross-linking and release properties of gelatin film
  1233. Evaluation of epigallocatechin-3-gallate (EGCG) modified collagen in guided bone regeneration (GBR) surgery and modulation of macrophage phenotype
  1234. Molecular determinants of the interaction of EGCG with ordered and disordered proteins
  1235. EGCG intestinal absorption and oral bioavailability enhancement using folic acid-functionalized nanostructured lipid carriers
  1236. Preparative Purification of Epigallocatechin-3-gallate (EGCG) from Tea Polyphenols by Adsorption Column Chromatography
  1237. In vitro regulation of osteoclast generation: A cost-effective strategy to combat osteoporosis with natural antioxidants and polyphenols like EGCG
  1238. RETRACTED ARTICLE: Human cathelicidin LL-37 enhance the antibiofilm effect of EGCG on Streptococcus mutans
  1239. Epigallocatechin‐3‐gallate (EGCG) and green tea polyphenols do not improve stallion semen parameters during cooling at 4° C
  1240. Profiling cytokine levels in chlorhexidine and EGCG-treated odontoblast-like cells
  1241. Green tea catechin, EGCG, enhances antitumor immunity by down-regulation of PD-L1 expression in non-small human lung cancer cell lines
  1242. (−)-Epigallocatechin-3-Gallate (EGCG) Enhances Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells
  1243. Effects of (−)-Epigallocatechin Gallate (EGCG) on Energy Expenditure and Microglia-Mediated Hypothalamic Inflammation in Mice Fed a High-Fat Diet
  1244. Glucose-regulated protein 78 substrate-binding domain alters its conformation upon EGCG inhibitor binding to nucleotide-binding domain: Molecular …
  1245. The design, synthesis and biological evaluation of pro-EGCG derivatives as novel anti-vitiligo agents
  1246. Epigallocatechin-3-gallate (EGCG) in or on nanoparticles: Enhanced stability and bioavailability of EGCG encapsulated in nanoparticles or targeted delivery of gold …
  1247. EGCG stimulates the recruitment of brite adipocytes, suppresses adipogenesis and counteracts TNF-α-triggered insulin resistance in adipocytes
  1248. Long-term supplementation with EGCG and beta-alanine decreases mortality but does not affect cognitive or muscle function in aged mice
  1249. Facile synthesis of 4″-O-alkyl-(–)-EGCG derivatives through regioselective deacetylative alkylation
  1250. Can EGCG Alleviate Symptoms of Down Syndrome by Altering Proteolytic Activity?
  1251. Epigallocatechin-3-gallate (EGCG) inhibits RANTES/CCL5 induced MMP-1 and MMP-13 expression in human rheumatoid arthritis synovial fibroblasts
  1252. Influence of aluminium and EGCG on fibrillation and aggregation of human islet amyloid polypeptide
  1253. Innovative cancer treatment of human lung cancer cells PC-9 with a synthetic retinoid Am80 and EGCG via inhibition of HDAC4 and HDAC5
  1254. Role of EGCG in Containing the Progression of Lung Tumorigenesis–A Multistage Targeting Approach
  1255. Protective effects of EGCG through Inhibition of NADPH oxidase expression in endothelial cells
  1256. Refractory pouchitis improves after administration of the green tea polyphenol EGCG: a retrospective review
  1257. The effect of altitude against total phenolic and Epigallocatechin Gallate (EGCG) content in green tea leaves
  1258. Green Tea Product Epigallocatechin Gallate (EGCG) Content and Label Information: A Descriptive Analysis
  1259. Effect of EGCG Application on Collagen Degradation in Dentine Caries
  1260. Restoring the activity of the antibiotic aztreonam using the polyphenol epigallocatechin gallate (EGCG) against multidrug-resistant clinical isolates of Pseudomonas …
  1261. Research progress on the effect and mechanism of EGCG in the prevention and treatment of diabetes mellitus.
  1262. Effects of EGCG on LPS-induced elevation of inflammatory factors in human gingival fibroblasts and functional mechanisms
  1263. Y-27632 Increases Sensitivity of PANC-1 Cells to Epigallocatechin Gallate (EGCG) in Regulating Cell Proliferation and Migration
  1264. THE EFFECT OF GREEN TEA EXTRACT-EPIGALLOCATECHIN GALLATE (EGCG) ON PORCINE OVARIAN GRANULOSA CELL
  1265. Study of EGCG induced apoptosis in lung cancer cells by inhibiting PI3K/Akt signaling pathway
  1266. (–)-Epigallocatechin-3-O-gallate (EGCG) attenuates the hemodynamics stimulated by caffeine through decrease of catecholamines release
  1267. Effects of green tea epigallocatechin-3-gallate (EGCG) on proteolipid protein (PLP) and oligodendrocyte transcription factor 1 (Olig1) expression in the cerebral cortex …
  1268. Epigallocatechin-3-gallate (EGCG) inhibits 3-hydroxy-3-methylglutaryl-CoA reductase in the presence of glycerol
  1269. Polymeric In Situ Hydrogel Implant of Epigallocatechin Gallate (EGCG) for Prolonged and Improved Antihyperlipidemic and Anti-Obesity Activity: Preparation and …
  1270. (−)-Epigallocatechin-3-gallate (EGCG) enhances healing of femoral bone defect
  1271. EGCG Maintains Th1/Th2 Balance and Mitigates Ulcerative Colitis Induced by Dextran Sulfate Sodium through TLR4/MyD88/NF-κB Signaling Pathway in Rats
  1272. Influence of EGCG on α‐synuclein (αS) aggregation and identification of their possible binding mode: A computational study using molecular dynamics simulation
  1273. Protective effect of epigallocatechin-3-gallate (EGCG) the major tea polyphenolic, against intracerebroventricularly colchicine induced oxidative damage …
  1274. Discriminatory analysis based molecular docking study for in silico identification of epigallocatechin-3-gallate (EGCG) derivatives as B-Raf V600E inhibitors
  1275. EGCG upregulated ABCA1 expression by decreasing miR-33 a generation to reduce lipid accumulation of macrophage-derived foam cells
  1276. Lipase catalyzed acetylation of EGCG, a lipid soluble antioxidant, and preparative purification by high-speed counter-current chromatography (HSCCC)
  1277. Differential expression of microRNAs contributed to the health efficacy of EGCG in in vitro subarachnoid hemorrhage model
  1278. Usage of and attitudes about green tea extract and Epigallocathechin-3-gallate (EGCG) as a therapy in individuals with Down syndrome
  1279. Oxidative stability and in vitro digestion of menhaden oil emulsions with whey protein: Effects of EGCG conjugation and interfacial cross-linking
  1280. Optimization of a novel kinetic-assisted infundation for rich-EGCG and polyphenols of white tea (Camellia sinensis) using central composite design
  1281. Dose-dependent decrease in mortality with no cognitive or muscle function improvements due to dietary EGCG supplementation in aged mice
  1282. Surface rearrangement of adsorbed EGCG–mucin complexes on hydrophilic surfaces
  1283. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) for use in the treatment of endometriosis
  1284. The Effects of EGCG-stearate on the Cellular Processes of HSV-1 Infected Vero Cells
  1285. Epigallocatechin-3-gallate (EGCG) up-regulates miR-15b expression thus attenuating store operated calcium entry (SOCE) into murine CD4+ T cells and …
  1286. PS 13-13 EGCG, A Green Tea Catechin, Attenuates The Progression Of Heart Failure Induced By The Heart/Muscle-Specific Deletion Of MnSOD In Mice
  1287. Impact of covalent or non-covalent bound epigallocatechin-3-gallate (EGCG) on assembly, physicochemical characteristics and digestion of ovotransferrin fibrils
  1288. Effects of Epigallocatechin-3-gallate (EGCG) on the bond strength of fiber posts to Sodium hypochlorite (NaOCl) treated intraradicular dentin
  1289. Recovery of (−)-epigallocatechingallate (EGCG) from aqueous solution by selective adsorption onto spent coffee grounds
  1290. Evidence of similar protective effects afforded by white tea and its active component ‘EGCG‘on oxidative-stress mediated hepatic dysfunction during benzo (a) pyrene …
  1291. Beneficial effect of (-)-epigallocatechin-3-gallate (EGCG) on sciatic nerve crush injury: stereological analysis
  1292. Chitosan-based nanoformulated (−)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced …
  1293. Improved antioxidant activity, bioaccessibility and bioavailability of EGCG by delivery in β-lactoglobulin particles
  1294. Epigallocatechin-3-gallate (EGCG) inhibits murine CD4+ T cell division and cell cycle progression through modulating cell cycle related-proteins
  1295. High-Resolution Adhesion Kinetics of EGCG-Exposed Tumor Cells on Biomimetic Interfaces: Comparative Monitoring of Cell Viability Using Label-Free Biosensor and …
  1296. Effects of SAHA and EGCG on Growth Potentiation of Triple-Negative Breast Cancer Cells
  1297. Biosynthesis of flower-shaped Au nanoclusters with EGCG and their application for drug delivery
  1298. EGCG ameliorating learning and memory impairment in APP/PS1 mice by inhibiting p75 NTR pathway
  1299. Targeting bacterial biofilms by the green tea polyphenol EGCG
  1300. EGCG sensitizes human nasopharyngeal carcinoma cells to TRAIL-mediated apoptosis by activation NF-κB.
  1301. Pathophysiological Responses Associated with Exposure to TQ and EGCG Using CAOV-3 Ovarian Cancer Like Cells.
  1302. Measurement of epigallocatechin gallate (EGCG) and caffeine content of 32 green tea dietary supplements for the Dietary Supplement Ingredient Database (DSID)
  1303. The advanced strategy for novel EGCG derivative modified liposome with high targeting ability to tumor
  1304. In Vitro Antioxidant effect of Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) in Protecting Cardiovascular Diseases
  1305. Correction to “High-Resolution Adhesion Kinetics of EGCG-Exposed Tumor Cells on Biomimetic Interfaces: Comparative Monitoring of Cell Viability Using Label-Free …
  1306. Effects of EGCG on nerve protection and BACE1 expression level in hippocampus of mice with Alzheimer’s disease
  1307. The Effects of Wortmannin and EGCG and Combined Treatments on MDA-MB-231 Breast Cancer Cell Lines via Inactivation of PI3K Signaling Pathway
  1308. Effect of EGCG on oxidative stress and Nrf2/HO-1 pathway in neurons exposed to oxygen-glucose deprivation/reperfusion
  1309. Study on inhibitory effect of EGCG on Calcium oxalate nephrolithiasis in rats and its related mechanism
  1310. Data in support of the negative influence of divalent cations on (−)-epigallocatechin-3-gallate (EGCG)-mediated inhibition of matrix metalloproteinase-2 (MMP …
  1311. Anti-Atherogenic Effects of Lesion-Targeted Epigallocatechin Gallate (EGCG)-Loaded Nanoparticles
  1312. Vitamin D enhances anticancer effects of EGCG and a specific micronutrient combination in breast cancer cells
  1313. Transcriptional profiling of Tu212 cell line treated with EGCG and resveratrol to identify actionable targets for adjuvant therapy.
  1314. Rapid colorimetric sensing of gadolinium by EGCG-derived AgNPs: the development of a nanohybrid bioimaging probe
  1315. Palmitate-induced insulin resistance is attenuated by Pioglitazone and EGCG through reducing the gluconeogenic key enzymes expression in HepG2 cells
  1316. Effects of EMD57033 and EGCG on Modulation of Ca2+-Sensitivity by Pka Phosphorylation
  1317. Combination of 5-Florouracil and polyphenol EGCG exerts suppressive effects on oral cancer cells exposed to radiation
  1318. A prospective, three-arm, randomized trial of EGCG for preventing radiation-induced esophagitis in lung cancer patients receiving radiotherapy
  1319. Effect of EGCG on oocytes in vitro maturation of buffalo (Bubalus bubalis).
  1320. Enhanced oral bioavailability of EGCG using pH-sensitive polymeric nanoparticles: characterization and in vivo investigation on nephrotic syndrome rats
  1321. Effect of β-cyclodextrin-EGCG complexion against aggregated a-synuclein through density functional theory and discrete molecular dynamics
  1322. Fabrication of supramolecular hyperbranched polyamidoamine–dextran conjugates and their self-assembly in the presence of EGCG
  1323. Effects of epigallocatechin-3-gallate (EGCG) on a scleroderma model of fibrosis
  1324. The combined administration of EGCG and caffeine induces not only suppression of fat accumulation but also anorexigenic action in mice
  1325. Investigation of the effect of different emulsifiers on the transdermal delivery of EGCG entrapped in a polymeric micelle system
  1326. EGCG enhances cancer cells sensitivity under 60Coγ radiation based on miR-34a/Sirt1/p53
  1327. EGCG overcomes gefitinib resistance by inhibiting autophagy and augmenting cell death through targeting ERK phosphorylation in NSCLC
  1328. EGCG inhibits CSC‐like properties through targeting miR‐485/CD44 axis in A549‐cisplatin resistant cells
  1329. Effects of epigallocatechin-3-gallate (EGCG) on skin greasiness and related gene expression in ‘Jonagold’apple fruit during ambient storage
  1330. EGCG stabilized pd nanoparticles, method for making, and electrochemical cell
  1331. Thymoquinone protects against EGCG/LPS induced hepatotoxicity in mice
  1332. Multifunctional mussel-inspired copolymerized epigallocatechin gallate (EGCG)/arginine coating: the potential as an ad-layer for vascular materials
  1333. Function, digestibility and allergenicity assessment of ovalbumin–EGCG conjugates
  1334. Cytoprotective Effect of Epigallocatechin Gallate (EGCG)-5′-O-α-Glucopyranoside, a Novel EGCG Derivative
  1335. Multiple antiviral approaches of (–)-epigallocatechin-3-gallate (EGCG) against porcine reproductive and respiratory syndrome virus infection in vitro
  1336. EGCG suppresses melanoma tumor angiogenesis and growth without affecting angiogenesis and VEGF expression in the heart and skeletal muscles in mice
  1337. Evaluation of the neuroprotective effect of EGCG: A potential mechanism of mitochondrial dysfunction and mitochondrial dynamics after subarachnoid hemorrhage
  1338. Continuous and selective separation of EGCG from tea polyphenols by fractional extraction: Experiment and simulation
  1339. Development of broccoli by-products as carriers for delivering EGCG
  1340. Encapsulation of (─)-epigallocatechin-3-gallate (EGCG) in solid lipid nanoparticles for food applications
  1341. Identification of epithelial‐specific ETS‐1 (ESE‐1) as a tumor suppressor and molecular target of green tea compound, EGCG
  1342. Review of Effectiveness of Green Tea Epigallocatechin Gallate (EGCG) on the inside and outside of human body
  1343. Divergent roles of Kupffer cell TLR2/3 signaling in alcoholic liver disease and the protective role of EGCG
  1344. Epigallocatechin-3-Gallate (EGCG) Suppresses Pancreatic Cancer Cell Growth, Invasion, and Migration partly through the Inhibition of Akt Pathway and Epithelial …
  1345. Treating Amyloidoses With A Vitamin B12 Composition Including Melatonin, Resveratrol, and EGCG
  1346. A-type ECG and EGCG dimers inhibit 3T3-L1 differentiation by binding to cholesterol in lipid rafts
  1347. Structural modification of (−)-epigallocatechin gallate (EGCG) shows significant enhancement in mitochondrial biogenesis
  1348. Chemoprevention of elite tea variety CFT‐1 rich in EGCG against chemically induced liver cancer in rats
  1349. Inhibition of HSV-1 Binding by EGCG-Stearate
  1350. Green Tea Epigallocathechin-3-gallate (EGCG)-A Natural Agent in the Fight Against Colorectal Cancer
  1351. Green Tea Polyphenol EGCG-S as an Antimicrobial Agent
  1352. EGCG stabilized gold nanoparticles and method for making same
  1353. Synthetic Epigallocatechin Gallate (EGCG) Analogs
  1354. … –Cytochrome P450/Cytochrome c by NMR and NMR Characterization of Monomeric and Oligomeric Conformations of Human Calcitonin and Its Interaction with EGCG …
  1355. Food-grade Zein Nanoparticles for Oral Delivery of Epigallocatechin-3-gallate (EGCG)
  1356. The effects of EGCG and EGCG-3Me on the bonding stability of dentin-adhensive to intraradicular dentin
  1357. EGCG from different sources: differential stability and effects on treating bone phenotypes related to Down syndrome
  1358. Effect of EGCG-Zn on the Learning, Memory and Antioxidant Abilities in Vascular Dementia Rats
  1359. Effect of dietary (-)-epigallocatechin-3-gallate (EGCG) pretreatment on the hepatotoxicity of acute high dose EGCG (270.3)
  1360. Study of protective effect of EGCG on immunological liver injury and relevant mechanism
  1361. A14070 EGCG attenuate cardiac hypertrophy in the hypertensive Dahl rats
  1362. the Effect of EGCG through Oral Gavage treatment on the Cerebellum in Down Syndrome
  1363. Synthesis and characterisation of epigallocatechin gallate (EGCG) conjugated gold nanoparticles and their effect on cellular migration and cancer invasion
  1364. The Effect of 200mg/kg EGCG Oral Gavage Treatment on the Cerebellar-Dependent Behavior in a Down Syndrome Mouse Model
  1365. Preparation, release and antioxidant property of EGCG loaded chitosan microparticles
  1366. Effects of EGCG on Cognitive Disorder of Type 2 Diabetes Mellitus Rats
  1367. Development and validation of bio-orthogonal probe to identify the molecular targets of (-)-epigallocatechin-3-gallate (EGCG), a major green tea polyphenol
  1368. Effects of Increased Dosage EGCG Treatment on Cognitive Deficits in the Ts65Dn Down Syndrome Mouse Model
  1369. Modified Green Tea Polyphenol, Palmitoyl-EGCG and Black Tea Theaflavins: Promising Natural Herpes Simplex Virus 1 and 2 Agents
  1370. Action of the Epigallocatechin-3-gallate (EGCG) on the inflammation on tenocytes culture
  1371. Directly binding to HNE and up-regulating α1-AT mediate the anti-migration effects of EGCG on neutrophil elastase-induced migration in A549 cells
  1372. Innate immune protein lipocalin-2 and iron mitigate EGCG-mediated inhibition of myeloperoxidase
  1373. Effects of EGCG Treatment of Ts65Dn Down Syndrome Mice on a Balance Beam Task
  1374. Effects of Epigallocatechin Gallate (EGCG) on Migration of Al, Fe and Mn in Yellow Earth Under the Interactions of Concentrations and pH Values
  1375. The potential synergistic effect of EGCG-S and antibiotics on the ESKAPE pathogens
  1376. Radiolabeling of EGCG with {sup 125} I and its biodistribution in mice
  1377. TARGETING MULTIPLE ALZHEIMER’S DISEASE ETIOLOGIES WITH EGCG LOADED PLA/PEG NANOPARTICLES
  1378. EGCG slows post-traumatic OA Progression: in vivo evidence and a novel mechanism underlying the downregulation of ADAMTS5
  1379. The effect of epigallocatechin gallate (EGCG) on the surface properties of nickel-chromium dental casting alloys after electrochemical corrosion
  1380. The mechanism study of EGCG on improvement of cognitive function and alleviation of hippocampal insulin resistance in APP/PS 1 transgenetic mice
  1381. EGCG Decreases Mortality in a Dose-Dependent Fashion but Does Not Improve Cognition in Aged Mice
  1382. Effect of EGCG on the expression of TLR4 and its downstream signal transduction pathway in human THP-1 monocytes
  1383. … of myofilament Ca2+-sensitivity from troponin I phosphorylation by hypertrophic and dilated cardiomyopathy mutations can be reversed by EGCG and related Hsp90 …
  1384. Fresh-keeping effect of EGCG on refrigerated tilapia fillet
  1385. The Effects of Epigallocatechin-3-gallate (EGCG) on Noise-Induced Cochlear Injury
  1386. Studying the interaction of PANI/EGCG in the electrochemical polymerization.
  1387. Effect of Epigallocatechin Gallate (EGCG) on Blood Pressure and Endothelial Function in Angiotensin II-Infused Hypertensive Mice
  1388. In vitro effects of EGCG on Schistosoma japonicum cercariae
  1389. Sustained Delivery of EGCG and TMQ On Fracture Healing Using Male Rats As A Model
  1390. The effect of EGCG and EGCG nanoparticles on body weight and body composition in LDL receptor null mice
  1391. Effects of addition sequence on structure and function of β-lactoglobulin-EGCG-glucose ternary complexes.
  1392. Have Some Tea, Feed Your Brain: How EGCG Acts as a Protective Agent in a Parkinsonian Model
  1393. Signifinace of cyclin D1 expression in CNE2 cells processed by EGCG
  1394. Inhibitory effect of (−)-epigallocatechin-3-gallate (EGCG) on toxicity induced by bisphenol A in bone marrow mesenchymal stem cell in adult rat
  1395. P-145 Oral Administration of EGCG, a Green Tea Polyphenol, Both Suppresses and Rescues Mice from DSS-Induced Colitis
  1396. Epigallocatechin-3-gallate (EGCG) inhibits IL-6-induced CRP synthesis and ameliorates adiponectin expression in Hep3B cells
  1397. Effects of EGCG on Proliferation, Cell Cycle and DAPK1 Gene Methylation of Acute Promyelocytic Leukemia NB4 Cell Line
  1398. THE EFFECT OF EGCG TREATMENT ON BRAIN MORPHOLOGY IN DOWN SYNDROME MOUSE MODELS
  1399. Effects of 50 mg/kg EGCG Treatment of Ts65Dn Down Syndrome Mice on Novel Object Recognition
  1400. METHOD VALIDATION FOR DETERMINATION OF (-)-EPIGALLOCATECHIN GALLATE (EGCG) STABILITY ON GREEN TEA EXTRACT SOLUTION PRODUCT …
  1401. Effects of EGCG Treatment on Cognitive Impairment in Ts65Dn Down Syndrome Mice
  1402. Advances in anti-tumor effect of catechins EGCG and its mechanism
  1403. Neuroprotective Effect of EGCG on Alzheimer Model Rats and Expression of PPARγ mRNA
  1404. Epigallocatechin-3-gallate (EGCG) ameliorates dextran sulfate sodium (DSS)–induced inflammatory bowel disease
  1405. Can Epigallocatechin gallate (EGCG) Treatment Rescue Hippocampal-Dependent Cognitive Function in a Down Syndrome Mouse Model?
  1406. The Effects of Epigallocatechin gallate (EGCG) on Cellular and Molecular Craniofacial Precursors
  1407. The Role of Metallothioneins in the Differential Pro-oxidant Effects of (-)-E pigallocatechin-3-gallate (EGCG) in Oral Cells
  1408. EGCG-gold nanoparticles exhibit greater anti-tumor activity over conventional gold nanoparticles or EGCG due to potential synergistic interactions
  1409. The Effects of Various Extraction Methods of the Antioxidant EGCG on Biofuel Production in Nannocholoropsis Salina
  1410. EGCG Treatment on Ts65Dn Mice Suggests a Possible Correlation in Cognitive Development Deficit Reduction
  1411. The effect of EGCG on the morphology and the expression of NAMPT with 131I radiation in rat parotid gland
  1412. Effects of EGCG treatment on deficits in a radial-arm maze spatial pattern separation task in a Down syndrome mouse model
  1413. Effect of high level of EGCG content in green tea extract on the catechins exposures profiles in different ocular compartment
  1414. Effect and mechanism of EGCG on improving insulin resistance induced by oleic acid in SW872 adipocytes
  1415. The Effect of (−)-Epigallocatechin-3-gallate (EGCG) on Cell Viability and Protein Expression in Human Pancreatic Cancer Cells (Panc-1) and Rat Osteosarcoma Cell …
  1416. Extended Treatment with a High Dosage of EGCG to Rescue Appendicular Bone Abnormalities in a Down Syndrome Mouse Model
  1417. Research Advance in Synthesis and Pharmacological Effects of EGCG Derivatives
  1418. EGCG protects formaldehyde‐induced apoptosis of lung epithelial cells
  1419. Mechanism study of EGCG on proliferation of human MGC-803 cell through Hedgehog pathway
  1420. Effects of Trisomic Dyrk1a and EGCG Treatment on Craniofacial Development in Ts65Dn Down Syndrome Mice
  1421. Dietary (-)-epigallocatechin-3-gallate (EGCG) supplementation counteracts metabolic disorders in senescence-accelerated mouse
  1422. Kupffer Cell TLR2/3 Signaling: A Pathway for EGCG Amelioration of Ethanol-Induced Hepatic Injury
  1423. Preservation of EGCG antioxidant properties by loading CS-PAA nanoparticles
  1424. Abstract A67: The effects of SAHA and EGCG on metastatic potential in triple-negative breast cancer
  1425. P390 The modulation of cardiac muscle Ca2+-sensitivity by PKA phosphorylation can be uncoupled by EMD57033 and re-coupled by EGCG.
  1426. EGCG promotes cell growth inhibition and reprograms mesenchymal-epithelial transition by restoring CCN5/WISP2 in triple negative breast cancer cells in vitro and in …
  1427. Effect of EGCG on Al, Fe and Mn in Yellow Soil Relative to Concentration and pH
  1428. Liposomal doxorubicin with modified EGCG increased antitumor activity by topical targeting efficiency into tumor
  1429. Three-Dimensional Analyses of Craniofacial and Oronasal Phenotypes in Ts65Dn Down Syndrome Mice Treated with EGCG, a Dyrk1a Inhibitor.
  1430. Effect of EGCG on granule cell proliferation in the adult dentate gyrus of the Ts65Dn mouse
  1431. EGCG, An Active Ingredient in Green Tea, Modulates Cell Proliferation in Human Pancreatic Cancer Cells and Rat Osteosarcoma Cells in vitro
  1432. A Morphometric Assessment of the Influence of EGCG on Down Syndrome Facial Morphology
  1433. Conceptualization Of Lact In Conjunction With EGCG For Cell-Targeting Apoptosis Within C. Elegans Utilized As A Rapidly Proliferating Cancer Model For …
  1434. Enzymatic oxidation products of EGCG and EC and their formation routes.
  1435. Hemodynamic Adrenergic Stimulation Can Be Attenuated By (-)-Epigallocatechin-3-O-Gallate (EGCG)
  1436. Reply: Green tea EGCG plus fish oil omega-3 dietary supplements rescue mitochondrial dysfunctions and are safe in a Down’s syndrome child
  1437. In vivo study of the renoprotective effects of EGCG in diabetic db/db mice
  1438. Pre-clinical evaluation of prostate specific membrane antigen (PSMA) nanobioconjugate encapsulating green tea polyphenol EGCG for prostate cancer
  1439. SAHA and EGCG affect metastatic potential to varying degrees in three triple-negative breast cancer cell lines
  1440. Aptamer conjugated prostate specific membrane antigen (PSMA) targeting EGCG nanobioconjugate for prostate cancer prevention and treatment
  1441. PROTECTIVE EFFECT OF EPIGALLOCATECHIN-3-GALLATE (EGCG) ON BLEOMYCIN INDUCED DNA DAMAGE IN HUMAN LYMPHOCYTES
  1442. Preparation of the Scales Material Adsorption EGCG
  1443. The effect of epigallocatechin-3-gallate (EGCG) on the push out bond strength of ah plus sealer to root dentin
  1444. EGCG inhibits LPS-caused polarization of macrophages into M1 phenotype via the NF-κB pathway.
  1445. The protective effects of EGCG on ischemia-reperfusion injury in rats with early pressure ulcer and mechanism related to NLRP3 inflammatory bodies
  1446. Role of EGCG on TGFbeta1-Ecadherin-Nrf2 Signaling in Colon Cancer
  1447. Effects of EGCG on Learning and Memory Abilities in mice with Alzeimer’s Disease
  1448. Green tea compound EGCG activates HBP1: an ALK downstream suppressor gene in neuroblastoma
  1449. Protective effects of EGCG against methylation changes induced by low dose radiation
  1450. Study on the effect of EGCG on the properties of fish skin collagen sheet
  1451. EGCG-A Promising Anti-Cancer Phytochemical.
  1452. Antihyperglycemic, Antidyslipidemic and Antifibrotic effect of EGCG in STZ-High Fat Diet Induced DCM rats
  1453. P118 Efficacy of microneedle patches containing salicylic acid or EGCG on acne vulgaris
  1454. The synergistic effect of Epigallocatechin-3-Gallate (EGCG) and Artemisinin on the Plasmodium mortality rates of Physarum polycephalum and cell motility/chemotaxis …
  1455. GW29-e0508 EGCG inhibits Angiotensin II-induced cardiac hypertrophy in H9C2 via activate HIPPO signaling pathway
  1456. NcRNAs fingerprints in colon cancer in vitro model by EGCG, genistein and their combinatorial effects
  1457. Mathematical Analysis of the Biophysical Response of EGCG-treated yperglycemic HMEC-1 and UMR Cells in vitro using Electric Cell-Substrate Impedance Sensing …
  1458. Study on Absorption of Theaflavin and EGCG in Caco-2 Cell Model
  1459. … : A phase II randomized, presurgical placebo-controlled trial of polyphenon E in bladder cancer patients to evaluate bladder tissue levels of EGCG and biomarkers of …
  1460. Molecular dynamics modelling of EGCG clusters on ceramide bilayers
  1461. GW26-e0504 EGCG attenuates uric acid-induced inflammatory responses by medicating the NOTCH pathway
  1462. Effects of (-)-Epigallocatechin gallate (EGCG) on proliferation and viability of Jurkat T-cells treated with ethanol
  1463. Cardioprotection of CPB-Induced Injuries by EGCG and Pulsatile Blood Flow
  1464. The Impact of Epigallocatechin-3-Gallate (EGCG) on Ts65Dn Down Syndrome Mouse Models
  1465. Research on the Pharmacokinetics and Elimination of Epigallocatechin Gallate (EGCG) in Mice
  1466. The Cosmetic and Therapeutic Uses for Epicatechin-3-Gallate (EGCG)
  1467. Enhancement of radiation induced oxidative stress in tumour cells by EGCG
  1468. in vitro Inhibitory Effects of Oolong Tea Polyphenols, EGCG and EGCG3” Me on α-Glucosidase Activity
  1469. Targeting cell signaling and apoptotic pathways by EGCG: A potential role in the prevention and treatment of ischemic heart disease
  1470. P042 GREEN TEA EXTRACT, EGCG, INHIBITS DNMT-1, ER STRESS AND PREVENTS THE DEVELOPMENT OF INTESTINAL FIBROSIS IN MURINE CHRONIC …
  1471. The Effect of Green Tea Polyphenol (EGCG) on Orthodontic Micro-Implant Stability: An experimental study
  1472. Living cells and copolymer coatings exposed to green tea polyphenol (EGCG): dynamic investigations using label-free optical biosensors
  1473. Screening of Epigallocatechin-3-Gallate (EGCG) Content in Camellia Sinensis Products
  1474. A Diet Containing EGCG and Beta-Alanine Decreases Mortality and Improves Balance in Aged Mice, but Does Not Affect Cognitive Function
  1475. Screening of Epigallocatechin-3-Gallate (EGCG) Content in Camellia sinensis Products
  1476. Investigation of the Function of Mammalian Trisomy 21 Gene Dyrk1A on Neuromuscular Signaling and the Restorative Effects of Polyphenol EGCG in C. elegans
  1477. AKTIVITAS ANTIBIOFILM Epigallocatechin gallate (EGCG) TERHADAP BAKTERI Streptococcus mutans
  1478. Monitoring and Modeling Effects of IGF1, Insulin and Green Tea Compound EGCG on Nuclear-Cytoplasmic Distribution of Foxo1-GFP in Skeletal Muscle Fibers
  1479. Effect of Cu2+ on antioxidant of EGCG
  1480. A novel role of HuR in‐Epigallocatechin‐3‐gallate (EGCG) induces tumour cells apoptosis
  1481. The upregulation of Myb and Peg3 may mediate EGCG inhibition effect on mouse lung adenocarcinoma
  1482. Comparative molecular docking studies of EGCG with SHaPrPC
  1483. The effects of insulin and EGCG on PANC-1 cell survival
  1484. Metabolomic analysis of epigallocatechin-gallate (EGCG)–treated human lymph node prostate carcinoma (LNCaP) cell line
  1485. Glucosylated Epigallocatechin Gallate (EGCG) Derivatives Combined with EGFR Tyrosine Kinase Inhibitor Overcome Resistance in EGFR T790M Mutant Lung …
  1486. Epigallocatechin-3-gallate (EGCG) exert therapeutic effect on acute inflammatory otitis media in rats
  1487. Dependency on p53 in Expression Changes of ATF3 and NAG-1 Induced by EGCG, Genistein, and Resveratrol
  1488. Development and Validation of RP-HPLC Method for Estimation of Epigallocatechin-3-gallate (EGCG) in Lipid based Nanoformulations
  1489. Synthesis, characterization and antioxidant activity of EGCG complexes with copper and zinc ions
  1490. A Convenient Manufacturing Method for Mass Production of EGCG Rich Green Tea Extract
  1491. Efikasi Pemberian Epigallocatechin gallate (EGCG) Topikal pada Penyembuhan Ulkus Plantar Pedis Kronis Morbus Hansen
  1492. Effect of quercetin, naringenin & EGCG on α1-adrenergic receptor-mediated vascular contraction in pulmonary artery of goat (Capra hircus)
  1493. Tag: EGCG
  1494. Current shreds of evidence on the anticancer role of EGCG in triple negative breast cancer: an update of the current state of knowledge
  1495. Resveratrol and EGCG bind directly and distinctively to miR-33a and miR-122 and modulate divergently their levels in hepatic cells
  1496. EGCG, a green tea polyphenol, as one more weapon in the arsenal to fight radiation esophagitis?
  1497. Antibacterial activities of green tea crude extracts and synergistic effects of epigallocatechingallate (EGCG) with gentamicin against MDR pathogens
  1498. Effects of EGCG and Chlorpyrifos on the Mortality, AChE and GSH of Adult Zebrafish: Independent and Combination
  1499. Enoxacin and Epigallocatechin Gallate (EGCG) Act Synergistically to Inhibit the Growth of Cervical Cancer Cells in Culture
  1500. A Mechanismic Study of EGCG on Macrophage-Derived Foam Cells: A Proteomic Analysis
  1501. EGCG, a major polyphenol in green tea, protects human retinal pigment epithelium (ARPE-19) cells from viable blue light-induced disorders
  1502. EGCG: Potential application as a protective agent against grass carp reovirus in aquaculture
  1503. AMELIORATIVE EFFECT OF (-) EPIGALLOCATECHIN GALLATE (EGCG) ON FENVALERATE INDUCED OXIDATIVE STRESS IN ERYTHROCYTES
  1504. Impact of diet-derived polyphenol EGCG on neurotensin response upon HL-60 promyelocytic leukemia cells acquisition of a macrophage-like phenotype
  1505. ESE-1/ELF3 Is a Tumor Suppressor and Molecular Target of Green Tea Compound, EGCG (P05-009-19)
  1506. Epigallocatechin-3-Gallate (EGCG): mechanisms, perspectives and clinical applications in cervical cancer
  1507. OXIDATIVE STRESS OF BIOACTIVE MOLECULES ANTIOXIDANT (EGCG) POLYPHENOLS EXTRACT OF GREEN TEA (CAMELLIA SINENSIS L.)
  1508. Effects of EGCG on proliferation and apoptosis of gastric cancer SGC7901 cells via down-regulation of HIF-1α and VEGF under a hypoxic state.
  1509. Inhibition of Herpes Simplex Virus-1 by the Modified Green Tea Polyphenol EGCG-Stearate
  1510. ANTI-CANCER ACTIVITIES OF THE GREEN TEA POLYPHENOLS EGC AND EGCG IN HUMAN MALIGNANT NEUROBLASTOMA
  1511. Drug-repositioning of the gallate group from EGCG for the repurposing
  1512. Epigallocatechin gallate (EGCG)–assisted combustion synthesis of V2O5 nanoparticles for Li-ion battery
  1513. In vitro evaluation of combination of EGCG and Erlotinib with classical chemotherapeutics on JAR cells
  1514. Composition of skin external application containing rose extract and epigallocatechin gallate (EGCG)
  1515. Enhanced bioaccessibility of green tea polyphenols and lipophilic activity of EGCG octaacetate on gram-negative bacteria
  1516. Anti-oxidative Effect of Silver Nano EGCG particles in Cigarette Smoke induced Alveolar Damage in Male Wistar Rats
  1517. Evaluation of epigallocatechin gallate (EGCG) to remove Pb (II) using spectroscopic and quantum chemical calculation method
  1518. Protective Effect of Green Tea Extract and EGCG on Ethanol-induced Cytotoxicity and DNA Damage in NIH/3T3 and HepG2 Cells
  1519. 3678-Pos Board B406 Effects of EMD57033 and EGCG on Modulation of Ca2D-Sensitivity by Pka Phosphorylation Andrew E. Messer, Mary Papadaki, Steven B …
  1520. EGCG and enzymatic cross‐linking combined treatments for improving elastin stability and reducing calcification in bioprosthetic heart valves
  1521. (-)-Epigallocatechin-3-gallate (EGCG), a polyphenol, protects against sepsis-induced acute liver injury in rats.
  1522. EGCG suppresses NF-κB activation induced by gastroesophageal reflux contents in human esophageal epithelial cells
  1523. 10 Green Tea Polyphenol EGCG-sensing Receptor
  1524. Chemoprevention by Epigallocatechin-3-Gallate (EGCG)
  1525. Study on the Mechanism of Epigallocatechin Gallate (EGCG) to the Cell Membrane of Escherichia coli
  1526. Epigallocatechin Gallate (EGCG) Inhibited the Alv-J-Induced Apoptosis in Df-1 Cells by Inactivation of Nuclear Factor κb Pathway
  1527. Are Females More Susceptible to EGCG Induced Hepatotoxicity?
  1528. A NOVEL SYNTHESIS METHOD OF LIPOPHILIC EGCG PALMITATE AND EVALUATION FOR ITS ALPHA AMYLASE AND ALPHA GLUCOSIDASE INHIBTORY …
  1529. Release Kinetics of Si, Al, Fe, and Mn from Acid Soils in the Presence of EGCG
  1530. The Effects of Curcumin and Epigallocatechin Gallate (EGCG) on Neurulation in Xenopus laevis
  1531. Do Catechins (ECG and EGCG) Bind to the Same Site as Thioflavin T (ThT) in Amyloid Fibril? Answer From Saturation Transfer Difference NMR
  1532. EGCG improves recombinant protein productivity in Chinese hamster ovary cell cultures via cell proliferation control
  1533. Oxidization increases the binding of EGCG to serum albumin revealed by kinetic data from label-free optical biosensor with reference channel
  1534. Effect of chlorhexidine, green tea and EGCG as therapeutic primers to increase the durability of resin-dentin bond
  1535. Improvement in fasting blood sugar, anthropometric measurement and hs-CRP after consumption of epigallocatechin-3-gallate (EGCG) in patients with type 2 …
  1536. Incorporation of EGCG into an etch-and-rinse adhesive system: mechanical properties and bond strength to caries affected dentin
  1537. Lipophilization of EGCG and effects on antioxidant activities
  1538. Supplementation with lower doses of EGCG reduces liver injury markers of type 2 diabetic rats
  1539. A dual-inhibitor system for the effective antifibrillation of Aβ40 peptides by biodegradable EGCG–Fe (iii)/PVP nanoparticles
  1540. Early antioxidant treatment with EGCG prevents diabetic neuropathic pain and oxidative stress damage in nociceptive spinal cord neurons
  1541. Radioprotection of EGCG based on immunoregulatory effect and antioxidant activity against 60Coγ radiation-induced injury in mice
  1542. Green Tea Polyphenol (−)-Epigallocatechin Gallate (EGCG) Attenuates Neuroinflammation in Palmitic Acid-Stimulated BV-2 Microglia and High-Fat Diet-Induced …
  1543. Attenuation of Cypermethrin Induced Nephrotoxicity by (-) Epigallocatechin Gallate (EGCG) in Male Wistar Rats
  1544. EGCG regulation of non-insulin-responsive endosomal compartments in insulin-resistant skeletal muscle
  1545. Green Tea Polyphenol, Epigallocatechin-3-Gallate (EGCG): Mechanisms and Application on Hepatocellular Carcinoma
  1546. Protection against Methamphetamine-Induced Striatal Apoptosis by Epigallocatechin Gallate (EGCG) in the Mouse Brain
  1547. Co‐Encapsulation of EGCG and Quercetin in Liposomes for Optimum Antioxidant Activity
  1548. Improvement of the osteogenic potential of ErhBMP-2-/EGCG-coated biphasic calcium phosphate bone substitute: in vitro and in vivo activity
  1549. Tea Leaf Age, Shade and Characteristic Levels of l-Theanine, Caffeine,(−)-Epigallocatechin Gallate (EGCG),(−)-Epigallocatechin (EGC),(−)-Epicatechin (EC), and (−) …
  1550. Induction of Endoplasmic Reticulum Stress Pathway by Green Tea Epigallocatechin-3-Gallate (EGCG) in Colorectal Cancer Cells: Activation of PERK/p-eIF2α/ATF4 …
  1551. EGCG induces G-CSF expression and neutrophilia in experimental sepsis
  1552. Immunotherapeutic Effect of EGCG and DAC Treatment for Triple Negative Breast Cancer
  1553. Interaction of Quercetin and Epigallocatechin Gallate (EGCG) Aggregates with Pancreatic Lipase Under Simplified Intestinal Conditions
  1554. Evaluation of (-)-epigallocatechin-3-gallate (EGCG)-induced cytotoxicity on astrocytes: A potential mechanism of calcium overloading-induced mitochondrial …
  1555. Optimization of brewing conditions in epigallocatechin-3-gallate (EGCG) extraction from Jinxuan summer green tea by response surface methodology
  1556. Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models
  1557. Conjugation Of EGCG And Chitosan NPs As A Novel Nano-Drug Delivery System
  1558. The protective role of Epigallocatechin gallate (EGCG) for renal damage by suppressing oxidative stress in rats induced by aluminum oxide nanoparticles
  1559. Protein Binding Characteristics of the Principal Green Tea Catechins: A QCM Study Comparing Crude Extract to Pure EGCG
  1560. Epigallocatechin-3-gallate (EGCG) inhibits aggregation of pulmonary fibrosis associated mutant surfactant protein A2 via a proteasomal degradation pathway
  1561. Cerebral protection of epigallocatechin gallate (EGCG) via preservation of mitochondrial function and ERK inhibition in a rat resuscitation model
  1562. Oxidation derivative of (-)-epigallocatechin-3-gallate (EGCG) inhibits RANKL-induced osteoclastogenesis by suppressing RANK signaling pathways in RAW …
  1563. Application of Electrochemical Techniques for Determining and Extracting Natural Product (EGCG) by the Synthesized Conductive Polymer Electrode (Ppy …
  1564. Retraction Note: Human cathelicidin LL-37 enhance the antibiofilm effect of EGCG on Streptococcus mutans
  1565. Comparative Evaluation of the Antibacterial, Anti-biofilm and Anti-spore Effects of Theaflavins and Palmitoyl-EGCG
  1566. Potentiation of nootropic activity of EGCG loaded nanosuspension by piperine in swiss male albino mice
  1567. Coadministration of epigallocatechin‐3‐gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats
  1568. Simultaneous determination of the pharmacokinetics of A-type EGCG and ECG dimers in mice plasma and its metabolites by UPLC-QTOF-MS
  1569. Prodrug of green tea epigallocatechin-3-gallate (pro-EGCG) for use in the treatment of endometriosis
  1570. Differential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non-small cells lung cancer to …
  1571. Encapsulation of EGCG and esterified EGCG derivatives in double emulsions containing Whey Protein Isolate, Bacterial Cellulose and salt
  1572. Evaluation of epigallocatechin-3-gallate (EGCG)-modified scaffold determines macrophage recruitment
  1573. Acute Epigallocatechin 3 Gallate (EGCG) Supplementation Delays Gastric Emptying in Healthy Women: A Randomized, Double-Blind, Placebo-Controlled Crossover …
  1574. White tea-A cost effective alternative to EGCG in fight against benzo (a) pyrene (BaP) induced lung toxicity in SD rats
  1575. Revealing the Mechanism of EGCG, Genistein, Rutin, Quercetin, and Silibinin Against hIAPP Aggregation via Computational Simulations
  1576. Nanofiltration membrane via EGCG-PEI co-deposition followed by cross-linking on microporous PTFE substrates for desalination
  1577. Prodrug of green tea epigallocatechin-3-gallate (pro-EGCG) for use in the treatment of endometriosis
  1578. Epigallocatechin-3-Gallate (EGCG), An Active Constituent of Green Tea: Implications in the Prevention of Liver Injury Induced by Diethylnitrosamine (DEN) in Rats
  1579. The protective role of Epigallocatechin gallate (EGCG) on oxidative stress in normal and treated rats with aluminum oxide nanoparticles
  1580. Effects of Epigallocatechin Gallate (EGCG) on Urinary Bladder Urothelial Carcinoma―Next-Generation Sequencing and Bioinformatics Approaches
  1581. Synergistic inhibition of lung cancer cells by EGCG and NF-κB inhibitor BAY11-7082
  1582. Development of Phyllanthus emblica (L) fruit as a carrier for EGCG: Interaction and in vitro digestion study
  1583. Running title: Epigallocatechin gallate (EGCG) inhibition of ricin
  1584. Effects of EGCG and DAC Combinational Treatment on Treating Triple Negative Breast Cancer and Aiding Immune Checkpoint Blockage Therapies
  1585. Bioavailability enhancement of EGCG by structural modification and nano-delivery: A review
  1586. Solubility Determination and Modeling of EGCG Peracetate in 12 Pure Solvents at Temperatures from 278.15 to 318.15 K
  1587. Prodrug of green tea epigallocatechin-3-gallate (pro-EGCG) for use in the treatment of endometriosis
  1588. Comparison of migration disturbance potency of epigallocatechin gallate (EGCG) synthetic analogs and EGCG PEGylated PLGA nanoparticles in rat neurospheres
  1589. Combined effect of pH and temperature on the stability and antioxidant capacity of epigallocatechin gallate (EGCG) in aqueous system
  1590. Conformation and Aggregation of Human Serum Albumin in the Presence of Green Tea Polyphenol (EGCG) and/or Palmitic Acid
  1591. Effects of quercetin, naringenin and EGCG on 5HT and histamine induced contraction in pulmonary artery and its modulation by hypoxia
  1592. A-type EGCG dimer, a new proanthocyanidins dimer from persimmon fruits, interacts with the amino acid residues of Aβ40 which possessed high aggregation …
  1593. Epigallocatechin gallate (EGCG) activity against UV light-induced photo damages in erythrocytes and serum albumin—theoretical and experimental studies
  1594. Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe …
  1595. Novel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in mice
  1596. EPIGALOCATEQUINA-3-GALATO (EGCG) DO CHÁ VERDE-UM AGENTE NATURAL CONTRA O CANCRO COLORECTAL
  1597. Enrichment of (−) epigallocatechin gallate (EGCG) from aqueous extract of green tea leaves by hollow fiber microfiltration: Modeling of flux decline and identification of …
  1598. Polymer-Assisted In Situ Synthesis of Silver Nanoparticles with Epigallocatechin Gallate (EGCG) Impregnated Wound Patch Potentiate Controlled …
  1599. Fabrication and characterization of soybean oil bodies encapsulated in maltodextrin and chitosan-EGCG conjugates: An in vitro digestibility study
  1600. Complex of EGCG with Cu (II) Suppresses Amyloid Aggregation and Cu (II)-Induced Cytotoxicity of α-Synuclein
  1601. SAHA and EGCG Promote Apoptosis in Triple-negative Breast Cancer Cells, Possibly Through the Modulation of cIAP2
  1602. EGCG protects cardiomyocytes against hypoxia-reperfusion injury through inhibition of OMA1 activation
  1603. Co-encapsulation of Epigallocatechin Gallate (EGCG) and Curcumin by Two Proteins-Based Nanoparticles: Role of EGCG
  1604. Epigallocatechin gallate (EGCG) alters body fat and lean mass through sex-dependent metabolic mechanisms in Drosophila melanogaster
  1605. The Environment Is a Key Factor in Determining the Anti-Amyloid Efficacy of EGCG
  1606. Evaluation of EGCG loading capacity in DMPC membranes
  1607. EGCG Inhibits Fibrillation of Light Chain 6aJL2-R24G, Associated with Light Chain Amyloidosis
  1608. The Effects of Epigallocatechin Gallate (EGCG) on Pulmonary Fibroblasts of Idiopathic Pulmonary Fibrosis (IPF)—A Next-Generation Sequencing and Bioinformatic …
  1609. … -active antioxidant biopolymers by using a grafted scallop (Patinopecten yessoensis) gonad protein isolate–epigallocatechin gallate (EGCG) conjugate: improving the …
  1610. EGCG-Derivative G28 Shows High Efficacy Inhibiting the Mammosphere-Forming Capacity of Sensitive and Resistant TNBC Models
  1611. Antibacterial Activity of Epigallocatechin-3-Gallate (EGCG) on Pseudomonas aeruginosa
  1612. (−)-Epigallocatechin Gallate (EGCG) Enhances the Sensitivity of Colorectal Cancer Cells to 5-FU by Inhibiting GRP78/NF-κB/miR-155-5p/MDR1 Pathway
  1613. Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models
  1614. Utilization of β-lactoglobulin-(−)-Epigallocatechin-3-gallate (EGCG) composite colloidal nanoparticles as stabilizers for lutein pickering emulsion
  1615. Combination of EGCG or methylated EGCG and a pde inhibitor
  1616. Polycaprolactone/Gelatin Nanofiber Membranes Containing EGCG-Loaded Liposomes and Their Potential Use for Skin Regeneration
  1617. Mg-Incorporated EGCG Coating on AZ31 with Biocompatible Corrosion Protection for Vascular Implants
  1618. EGCG maintained Nrf2-mediated redox homeostasis and minimized etoposide resistance in lung cancer cells
  1619. Peptide–Polyphenol (KLVFF/EGCG) Binary Modulators for Inhibiting Aggregation and Neurotoxicity of Amyloid-β Peptide
  1620. Expanding Metabolic Targets in Cancer by Select Combinations of Vitamin C and EGCG with Different Natural Compounds
  1621. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer’s …
  1622. The Potential Synergistic Effect f EGCG-S and Antibiotics on the ESKAPE Bacteria Group
  1623. Methods and compositions for improving bioavailability of epigallocatechin gallate (EGCG)
  1624. Intracellular uptake of EGCG-loaded deformable controlled release liposomes for skin cancer
  1625. Alleviation of metabolic syndrome by green tea polyphenol EGCG: molecular mechanism involving amp-activated protein kinase
  1626. Shelf-stable, clear liquid nutritional compositions comprising epigallocatechin gallate (EGCG) and methods for preparing the same
  1627. Shelf-stable, clear liquid nutritional compositions comprising epigallocatechin galate (EGCG) and methods for preparing the same
  1628. Effect of tea and tea polyphenols EGCG and TF on stem cell renewal pathways during oral and liver carcinogenesis induced by N nitrosodiethyl amine NDEA
  1629. Methods for enhancing the effect of EGCG on mitigating skeletal muscle loss
  1630. Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease
  1631. Suppression, disaggregation, and modulation of γ‐Synuclein fibrillation pathway by green tea polyphenol EGCG
  1632. EGCG stabilized gold nanoparticles, therapies and sensing
  1633. A Small Molecule EGCG-S, a Modified Green Tea Polyphenol, as a Synergistic Agent to Enhance Antibacterial Activity of Antibiotics on Bacterial Biofilms
  1634. Methods for enhancing the effect of EGCG on mitigating skeletal muscle loss
  1635. Curcumin and EGCG: Potential cancer therapeutics
  1636. The Impact of EGCG in Combination with the Anti-Diabetic Drugs in Altering PANC-1Cell Line Survival
  1637. Lipophilized derivatives of epigallocatechin gallate (EGCG): preparations and bioactivities
  1638. Effect of green tea polyphenol, EGCG, on insulin sensitivity
  1639. Impact of epigallocatechin-3-gallate (EGCG), a broad-spectrum anti-inflammatory, in controlling intestinal factors contributing to inflammatory bowel disease.
  1640. Green Tea (EGCG), Insulin, IGF-1 Suppression of Atrophy Associated Transcription Factor Foxo1 Activity in Skeletal Muscle and Mathematical Modeling of Nuclear …
  1641. The differential pro-oxidant effects of the tea (Camellia Sinensis) catechin,(-)-epigallocatechin-3-gallate (EGCG), in the context of oral cancer
  1642. Effects of DHA and EGCG on the alpha-secretase mediated processing of APP
  1643. Oral Administration of Epigallocatechin-3-Gallate (EGCG) is a Potential Therapeutic for Cisplatin-Induced Hearing Loss
  1644. Effect of Dietary Pretreatment and Obesity on (-)-Epigallocatechin-3-gallate (EGCG) Mediated Hepatotoxicity and the Underlying Mechanism
  1645. Unfolding the Hsp90 Foldasome: Structure-Activity Relationship Studies on EGCG and Development of Isoform-Selective Inhibitors
  1646. … tea polifenollal (EGCG): dinamikai vizsgálatok jelölésmentes bioszenzorokkal= Living cells and copolymer coatings exposed to green tea polyphenol (EGCG) …
  1647. The Effects of SAHA and EGCG on Metastatic Potential in Triplenegative Breast Cancer Cells
  1648. Suppression of the Progressive Behavior of Ovarian Cancer like Cells using Thymoquinone (TQ) and Epigallocatechin-3-gallate (EGCG) in vitro

Related Posts

Shopping Cart
Scroll to Top